id	sid	tid	token	lemma	pos
gra-1922	1	1	introduction	introduction	NOUN
gra-1922	1	2	according	accord	VERB
gra-1922	1	3	to	to	ADP
gra-1922	1	4	world	world	PROPN
gra-1922	1	5	health	health	NOUN
gra-1922	1	6	organization	organization	NOUN
gra-1922	1	7	,	,	PUNCT
gra-1922	1	8	worldwide	worldwide	ADV
gra-1922	1	9	cervical	cervical	ADJ
gra-1922	1	10	cancer	cancer	NOUN
gra-1922	1	11	is	be	AUX
gra-1922	1	12	the	the	DET
gra-1922	1	13	fourth	fourth	ADJ
gra-1922	1	14	most	most	ADV
gra-1922	1	15	common	common	ADJ
gra-1922	1	16	cancer	cancer	NOUN
gra-1922	1	17	among	among	ADP
gra-1922	1	18	females	female	NOUN
gra-1922	1	19	and	and	CCONJ
gra-1922	1	20	the	the	DET
gra-1922	1	21	disease	disease	NOUN
gra-1922	1	22	burden	burden	NOUN
gra-1922	1	23	is	be	AUX
gra-1922	1	24	estimated	estimate	VERB
gra-1922	1	25	to	to	PART
gra-1922	1	26	be	be	AUX
gra-1922	1	27	570,000	570,000	NUM
gra-1922	1	28	new	new	ADJ
gra-1922	1	29	cases	case	NOUN
gra-1922	1	30	in	in	ADP
gra-1922	1	31	2018	2018	NUM
gra-1922	1	32	i.e.	i.e.	ADV
gra-1922	1	33	attributing	attribute	VERB
gra-1922	1	34	to	to	ADP
gra-1922	1	35	6.6	6.6	NUM
gra-1922	1	36	%	%	NOUN
gra-1922	1	37	of	of	ADP
gra-1922	1	38	all	all	DET
gra-1922	1	39	female	female	ADJ
gra-1922	1	40	cancers	cancer	NOUN
gra-1922	1	41	and	and	CCONJ
gra-1922	1	42	leading	lead	VERB
gra-1922	1	43	[	[	X
gra-1922	1	44	1,2]to	1,2]to	NUM
gra-1922	1	45	approximately	approximately	ADV
gra-1922	1	46	311000	311000	NUM
gra-1922	1	47	deaths	death	NOUN
gra-1922	1	48	in	in	ADP
gra-1922	1	49	2018	2018	NUM
gra-1922	1	50	.	.	PUNCT
gra-1922	2	1	the	the	DET
gra-1922	2	2	age	age	NOUN
gra-1922	2	3	standardised	standardise	VERB
gra-1922	2	4	incidence	incidence	NOUN
gra-1922	2	5	of	of	ADP
gra-1922	2	6	cervical	cervical	ADJ
gra-1922	2	7	cancer	cancer	NOUN
gra-1922	2	8	was	be	AUX
gra-1922	2	9	estimated	estimate	VERB
gra-1922	2	10	to	to	PART
gra-1922	2	11	be	be	AUX
gra-1922	2	12	13.1	13.1	NUM
gra-1922	2	13	per	per	ADP
gra-1922	2	14	100000	100000	NUM
gra-1922	2	15	women	woman	NOUN
gra-1922	2	16	globally	globally	ADV
gra-1922	2	17	and	and	CCONJ
gra-1922	2	18	the	the	DET
gra-1922	2	19	incidence	incidence	NOUN
gra-1922	2	20	is	be	AUX
gra-1922	2	21	different	different	ADJ
gra-1922	2	22	in	in	ADP
gra-1922	2	23	different	different	ADJ
gra-1922	2	24	countries	country	NOUN
gra-1922	2	25	ranging	range	VERB
gra-1922	2	26	from	from	ADP
gra-1922	2	27	less	less	ADJ
gra-1922	2	28	than	than	ADP
gra-1922	2	29	2	2	NUM
gra-1922	2	30	to	to	PART
gra-1922	2	31	75	75	NUM
gra-1922	2	32	per	per	ADP
gra-1922	2	33	100000	100000	NUM
gra-1922	2	34	[	[	SYM
gra-1922	2	35	2]women	2]woman	NOUN
gra-1922	2	36	.	.	PUNCT
gra-1922	3	1	the	the	DET
gra-1922	3	2	occurrence	occurrence	NOUN
gra-1922	3	3	of	of	ADP
gra-1922	3	4	new	new	ADJ
gra-1922	3	5	cases	case	NOUN
gra-1922	3	6	of	of	ADP
gra-1922	3	7	cervical	cervical	ADJ
gra-1922	3	8	cancer	cancer	NOUN
gra-1922	3	9	in	in	ADP
gra-1922	3	10	india	india	PROPN
gra-1922	3	11	was	be	AUX
gra-1922	3	12	reported	report	VERB
gra-1922	3	13	to	to	ADP
gra-1922	3	14	106000	106000	NUM
gra-1922	3	15	and	and	CCONJ
gra-1922	3	16	contributing	contribute	VERB
gra-1922	3	17	to	to	ADP
gra-1922	3	18	60000	60000	NUM
gra-1922	4	1	[	[	X
gra-1922	4	2	2]deaths	2]deaths	NUM
gra-1922	4	3	.	.	PUNCT
gra-1922	5	1	cervical	cervical	ADJ
gra-1922	5	2	cancer	cancer	NOUN
gra-1922	5	3	is	be	AUX
gra-1922	5	4	the	the	DET
gra-1922	5	5	major	major	ADJ
gra-1922	5	6	public	public	ADJ
gra-1922	5	7	health	health	NOUN
gra-1922	5	8	problem	problem	NOUN
gra-1922	5	9	affecting	affect	VERB
gra-1922	5	10	middle	middle	ADJ
gra-1922	5	11	-	-	PUNCT
gra-1922	5	12	aged	aged	ADJ
gra-1922	5	13	women	woman	NOUN
gra-1922	5	14	,	,	PUNCT
gra-1922	5	15	particularly	particularly	ADV
gra-1922	5	16	in	in	ADP
gra-1922	5	17	low	low	ADJ
gra-1922	5	18	and	and	CCONJ
gra-1922	5	19	middle	middle	ADJ
gra-1922	5	20	income	income	NOUN
gra-1922	6	1	[	[	X
gra-1922	6	2	2	2	NUM
gra-1922	6	3	]	]	PUNCT
gra-1922	6	4	countries	country	NOUN
gra-1922	6	5	.	.	PUNCT
gra-1922	7	1	usually	usually	ADV
gra-1922	7	2	the	the	DET
gra-1922	7	3	cases	case	NOUN
gra-1922	7	4	with	with	ADP
gra-1922	7	5	cervical	cervical	ADJ
gra-1922	7	6	cancer	cancer	NOUN
gra-1922	7	7	have	have	VERB
gra-1922	7	8	favorable	favorable	ADJ
gra-1922	7	9	prognosis	prognosis	NOUN
gra-1922	7	10	if	if	SCONJ
gra-1922	7	11	diagnosed	diagnose	VERB
gra-1922	7	12	and	and	CCONJ
gra-1922	7	13	treated	treat	VERB
gra-1922	7	14	in	in	ADP
gra-1922	7	15	early	early	ADJ
gra-1922	7	16	stage	stage	NOUN
gra-1922	7	17	with	with	ADP
gra-1922	7	18	estimated	estimate	VERB
gra-1922	7	19	5	5	NUM
gra-1922	7	20	year	year	NOUN
gra-1922	7	21	survival	survival	NOUN
gra-1922	7	22	rate	rate	NOUN
gra-1922	7	23	of	of	ADP
gra-1922	7	24	80	80	NUM
gra-1922	7	25	-	-	SYM
gra-1922	7	26	90	90	NUM
gra-1922	7	27	%	%	NOUN
gra-1922	7	28	.	.	PUNCT
gra-1922	8	1	however	however	ADV
gra-1922	8	2	,	,	PUNCT
gra-1922	8	3	[	[	X
gra-1922	8	4	3]advanced	3]advanced	ADJ
gra-1922	8	5	disease	disease	NOUN
gra-1922	8	6	are	be	AUX
gra-1922	8	7	associated	associate	VERB
gra-1922	8	8	with	with	ADP
gra-1922	8	9	poor	poor	ADJ
gra-1922	8	10	prognosis	prognosis	NOUN
gra-1922	8	11	.	.	PUNCT
gra-1922	9	1	current	current	ADJ
gra-1922	9	2	treatment	treatment	NOUN
gra-1922	9	3	for	for	ADP
gra-1922	9	4	locally	locally	ADV
gra-1922	9	5	advanced	advanced	ADJ
gra-1922	9	6	cancer	cancer	NOUN
gra-1922	9	7	cervix	cervix	NOUN
gra-1922	9	8	where	where	SCONJ
gra-1922	9	9	surgical	surgical	ADJ
gra-1922	9	10	treatment	treatment	NOUN
gra-1922	9	11	is	be	AUX
gra-1922	9	12	not	not	PART
gra-1922	9	13	indicated	indicate	VERB
gra-1922	9	14	include	include	VERB
gra-1922	9	15	cisplatin	cisplatin	NOUN
gra-1922	9	16	-	-	PUNCT
gra-1922	9	17	based	base	VERB
gra-1922	9	18	concurrent	concurrent	ADJ
gra-1922	9	19	chemoradiation	chemoradiation	NOUN
gra-1922	9	20	(	(	PUNCT
gra-1922	9	21	crt	crt	PROPN
gra-1922	9	22	)	)	PUNCT
gra-1922	9	23	based	base	VERB
gra-1922	9	24	on	on	ADP
gra-1922	9	25	ve	ve	PROPN
gra-1922	9	26	randomized	randomize	VERB
gra-1922	9	27	[	[	PUNCT
gra-1922	9	28	4,5,6,7,8,9	4,5,6,7,8,9	NUM
gra-1922	9	29	]	]	X
gra-1922	9	30	2trials	2trials	NUM
gra-1922	9	31	.	.	PUNCT
gra-1922	10	1	weekly	weekly	ADJ
gra-1922	10	2	cisplatin	cisplatin	NOUN
gra-1922	10	3	in	in	ADP
gra-1922	10	4	a	a	DET
gra-1922	10	5	dose	dose	NOUN
gra-1922	10	6	of	of	ADP
gra-1922	10	7	40	40	NUM
gra-1922	10	8	mg	mg	NOUN
gra-1922	10	9	/	/	SYM
gra-1922	10	10	m	m	PROPN
gra-1922	10	11	is	be	AUX
gra-1922	10	12	the	the	DET
gra-1922	10	13	most	most	ADV
gra-1922	10	14	widely	widely	ADV
gra-1922	10	15	accepted	accept	VERB
gra-1922	10	16	standard	standard	ADJ
gra-1922	10	17	regimen	regiman	NOUN
gra-1922	10	18	of	of	ADP
gra-1922	10	19	crt	crt	NOUN
gra-1922	10	20	because	because	SCONJ
gra-1922	10	21	of	of	ADP
gra-1922	10	22	its	its	PRON
gra-1922	10	23	convenience	convenience	NOUN
gra-1922	10	24	,	,	PUNCT
gra-1922	10	25	equal	equal	ADJ
gra-1922	10	26	effectiveness	effectiveness	NOUN
gra-1922	10	27	,	,	PUNCT
gra-1922	10	28	and	and	CCONJ
gra-1922	10	29	favorable	favorable	ADJ
gra-1922	10	30	toxicity	toxicity	NOUN
gra-1922	10	31	in	in	ADP
gra-1922	10	32	[	[	X
gra-1922	10	33	10]comparison	10]comparison	NUM
gra-1922	10	34	to	to	ADP
gra-1922	10	35	other	other	ADJ
gra-1922	10	36	5	5	NUM
gra-1922	10	37	-	-	PUNCT
gra-1922	10	38	fu	fu	NOUN
gra-1922	10	39	combined	combine	VERB
gra-1922	10	40	regimens	regimen	NOUN
gra-1922	10	41	.	.	PUNCT
gra-1922	11	1	however	however	ADV
gra-1922	11	2	,	,	PUNCT
gra-1922	11	3	[	[	X
gra-1922	11	4	11,12,13]various	11,12,13]various	NUM
gra-1922	11	5	trials	trial	NOUN
gra-1922	11	6	have	have	AUX
gra-1922	11	7	used	use	VERB
gra-1922	11	8	3	3	NUM
gra-1922	11	9	weekly	weekly	ADJ
gra-1922	11	10	cisplatin	cisplatin	NOUN
gra-1922	11	11	in	in	ADP
gra-1922	11	12	a	a	DET
gra-1922	11	13	dose	dose	NOUN
gra-1922	11	14	of	of	ADP
gra-1922	11	15	275–100	275–100	NUM
gra-1922	11	16	mg	mg	PROPN
gra-1922	11	17	/	/	SYM
gra-1922	11	18	m	m	PROPN
gra-1922	11	19	as	as	SCONJ
gra-1922	11	20	this	this	DET
gra-1922	11	21	form	form	NOUN
gra-1922	11	22	of	of	ADP
gra-1922	11	23	chemotherapy	chemotherapy	NOUN
gra-1922	11	24	is	be	AUX
gra-1922	11	25	easy	easy	ADJ
gra-1922	11	26	to	to	PART
gra-1922	11	27	administer	administer	VERB
gra-1922	11	28	and	and	CCONJ
gra-1922	11	29	is	be	AUX
gra-1922	11	30	associated	associate	VERB
gra-1922	11	31	with	with	ADP
gra-1922	11	32	better	well	ADJ
gra-1922	11	33	patient	patient	ADJ
gra-1922	11	34	compliance	compliance	NOUN
gra-1922	11	35	.	.	PUNCT
gra-1922	12	1	the	the	DET
gra-1922	12	2	present	present	ADJ
gra-1922	12	3	study	study	NOUN
gra-1922	12	4	was	be	AUX
gra-1922	12	5	conducted	conduct	VERB
gra-1922	12	6	to	to	PART
gra-1922	12	7	assess	assess	VERB
gra-1922	12	8	the	the	DET
gra-1922	12	9	efcacy	efcacy	NOUN
gra-1922	12	10	and	and	CCONJ
gra-1922	12	11	toxicity	toxicity	NOUN
gra-1922	12	12	prole	prole	PROPN
gra-1922	12	13	of	of	ADP
gra-1922	12	14	concurrent	concurrent	ADJ
gra-1922	12	15	weekly	weekly	ADJ
gra-1922	12	16	cisplatin	cisplatin	NOUN
gra-1922	12	17	dosing	dose	VERB
gra-1922	12	18	as	as	SCONJ
gra-1922	12	19	compared	compare	VERB
gra-1922	12	20	to	to	ADP
gra-1922	12	21	3	3	NUM
gra-1922	12	22	weekly	weekly	ADJ
gra-1922	12	23	cisplatin	cisplatin	NOUN
gra-1922	12	24	alone	alone	ADJ
gra-1922	12	25	with	with	ADP
gra-1922	12	26	radiotherapy	radiotherapy	NOUN
gra-1922	12	27	in	in	ADP
gra-1922	12	28	patients	patient	NOUN
gra-1922	12	29	of	of	ADP
gra-1922	12	30	cervical	cervical	ADJ
gra-1922	12	31	cancer	cancer	NOUN
gra-1922	12	32	and	and	CCONJ
gra-1922	12	33	also	also	ADV
gra-1922	12	34	to	to	PART
gra-1922	12	35	evaluate	evaluate	VERB
gra-1922	12	36	the	the	DET
gra-1922	12	37	compliance	compliance	NOUN
gra-1922	12	38	among	among	ADP
gra-1922	12	39	them	they	PRON
gra-1922	12	40	.	.	PUNCT
gra-1922	13	1	methodology	methodology	NOUN
gra-1922	13	2	the	the	DET
gra-1922	13	3	present	present	ADJ
gra-1922	13	4	study	study	NOUN
gra-1922	13	5	was	be	AUX
gra-1922	13	6	conducted	conduct	VERB
gra-1922	13	7	as	as	ADP
gra-1922	13	8	a	a	DET
gra-1922	13	9	prospective	prospective	ADJ
gra-1922	13	10	randomized	randomized	ADJ
gra-1922	13	11	comparative	comparative	ADJ
gra-1922	13	12	study	study	NOUN
gra-1922	13	13	at	at	ADP
gra-1922	13	14	sanjay	sanjay	PROPN
gra-1922	13	15	gandhi	gandhi	PROPN
gra-1922	13	16	memorial	memorial	PROPN
gra-1922	13	17	hospital	hospital	PROPN
gra-1922	13	18	shyam	shyam	PROPN
gra-1922	13	19	shah	shah	PROPN
gra-1922	13	20	medical	medical	PROPN
gra-1922	13	21	college	college	PROPN
gra-1922	13	22	rewa	rewa	PROPN
gra-1922	13	23	,	,	PUNCT
gra-1922	13	24	for	for	ADP
gra-1922	13	25	a	a	DET
gra-1922	13	26	period	period	NOUN
gra-1922	13	27	of	of	ADP
gra-1922	13	28	1	1	NUM
gra-1922	13	29	st	st	NOUN
gra-1922	13	30	styear	styear	NOUN
gra-1922	13	31	i.e.	i.e.	X
gra-1922	13	32	from	from	ADP
gra-1922	13	33	1	1	NUM
gra-1922	13	34	april	april	PROPN
gra-1922	13	35	2018	2018	NUM
gra-1922	13	36	to	to	ADP
gra-1922	13	37	31	31	NUM
gra-1922	13	38	march	march	PROPN
gra-1922	13	39	2019	2019	NUM
gra-1922	13	40	.	.	PUNCT
gra-1922	14	1	the	the	DET
gra-1922	14	2	inclusion	inclusion	NOUN
gra-1922	14	3	criteria	criterion	NOUN
gra-1922	14	4	of	of	ADP
gra-1922	14	5	the	the	DET
gra-1922	14	6	study	study	NOUN
gra-1922	14	7	were	be	AUX
gra-1922	14	8	patients	patient	NOUN
gra-1922	14	9	with	with	ADP
gra-1922	14	10	histopathologically	histopathologically	ADV
gra-1922	14	11	proven	prove	VERB
gra-1922	14	12	locally	locally	ADV
gra-1922	14	13	advanced	advance	VERB
gra-1922	14	14	squamous	squamous	ADJ
gra-1922	14	15	cell	cell	NOUN
gra-1922	14	16	carcinoma	carcinoma	NOUN
gra-1922	14	17	cervix	cervix	NOUN
gra-1922	14	18	;	;	PUNCT
gra-1922	14	19	locally	locally	ADV
gra-1922	14	20	advance	advance	NOUN
gra-1922	14	21	disease	disease	NOUN
gra-1922	14	22	.	.	PUNCT
gra-1922	15	1	(	(	PUNCT
gra-1922	15	2	figo	figo	ADJ
gra-1922	15	3	stage	stage	NOUN
gra-1922	15	4	ib2	ib2	NOUN
gra-1922	15	5	-	-	PUNCT
gra-1922	15	6	iva	iva	NOUN
gra-1922	15	7	)	)	PUNCT
gra-1922	15	8	;	;	PUNCT
gra-1922	15	9	age	age	NOUN
gra-1922	15	10	>	>	X
gra-1922	15	11	18	18	NUM
gra-1922	15	12	but	but	CCONJ
gra-1922	15	13	<	<	X
gra-1922	15	14	70	70	NUM
gra-1922	15	15	years	year	NOUN
gra-1922	15	16	;	;	PUNCT
gra-1922	15	17	ecog	ecog	VERB
gra-1922	15	18	performance	performance	NOUN
gra-1922	15	19	0	0	NUM
gra-1922	15	20	-	-	SYM
gra-1922	15	21	1	1	NUM
gra-1922	15	22	-	-	SYM
gra-1922	15	23	2	2	NUM
gra-1922	15	24	;	;	PUNCT
gra-1922	15	25	consenting	consent	VERB
gra-1922	15	26	for	for	ADP
gra-1922	15	27	the	the	DET
gra-1922	15	28	study	study	NOUN
gra-1922	15	29	and	and	CCONJ
gra-1922	15	30	karnofsky	karnofsky	ADJ
gra-1922	15	31	performance	performance	NOUN
gra-1922	15	32	status	status	NOUN
gra-1922	15	33	at	at	ADP
gra-1922	15	34	least	least	ADV
gra-1922	15	35	40	40	NUM
gra-1922	15	36	.	.	PUNCT
gra-1922	16	1	whereas	whereas	SCONJ
gra-1922	16	2	patients	patient	NOUN
gra-1922	16	3	with	with	ADP
gra-1922	16	4	haematological	haematological	ADJ
gra-1922	16	5	,	,	PUNCT
gra-1922	16	6	cardiac	cardiac	ADJ
gra-1922	16	7	,	,	PUNCT
gra-1922	16	8	renal	renal	ADJ
gra-1922	16	9	or	or	CCONJ
gra-1922	16	10	liver	liver	NOUN
gra-1922	16	11	function	function	NOUN
gra-1922	16	12	abnormalities	abnormality	NOUN
gra-1922	16	13	;	;	PUNCT
gra-1922	16	14	hypersensitivity	hypersensitivity	NOUN
gra-1922	16	15	to	to	PART
gra-1922	16	16	cisplatin	cisplatin	NOUN
gra-1922	16	17	with	with	ADP
gra-1922	16	18	distant	distant	ADJ
gra-1922	16	19	metastasis	metastasis	NOUN
gra-1922	16	20	;	;	PUNCT
gra-1922	16	21	prior	prior	ADJ
gra-1922	16	22	radiotherapy	radiotherapy	NOUN
gra-1922	16	23	;	;	PUNCT
gra-1922	16	24	karnofsky	karnofsky	ADJ
gra-1922	16	25	performance	performance	NOUN
gra-1922	16	26	status	status	NOUN
gra-1922	16	27	<	<	PROPN
gra-1922	16	28	40	40	NUM
gra-1922	16	29	;	;	PUNCT
gra-1922	16	30	pregnant	pregnant	ADJ
gra-1922	16	31	and	and	CCONJ
gra-1922	16	32	lactating	lactating	NOUN
gra-1922	16	33	;	;	PUNCT
gra-1922	16	34	with	with	ADP
gra-1922	16	35	history	history	NOUN
gra-1922	16	36	of	of	ADP
gra-1922	16	37	prior	prior	ADJ
gra-1922	16	38	chemotherapy	chemotherapy	NOUN
gra-1922	16	39	(	(	PUNCT
gra-1922	16	40	neoadjuvant	neoadjuvant	ADJ
gra-1922	16	41	)	)	PUNCT
gra-1922	16	42	,	,	PUNCT
gra-1922	16	43	metastatic	metastatic	ADJ
gra-1922	16	44	cancer	cancer	NOUN
gra-1922	16	45	and	and	CCONJ
gra-1922	16	46	other	other	ADJ
gra-1922	16	47	synchronous	synchronous	ADJ
gra-1922	16	48	malignancies	malignancy	NOUN
gra-1922	16	49	were	be	AUX
gra-1922	16	50	excluded	exclude	VERB
gra-1922	16	51	from	from	ADP
gra-1922	16	52	the	the	DET
gra-1922	16	53	study	study	NOUN
gra-1922	16	54	.	.	PUNCT
gra-1922	17	1	a	a	DET
gra-1922	17	2	total	total	NOUN
gra-1922	17	3	of	of	ADP
gra-1922	17	4	80	80	NUM
gra-1922	17	5	patients	patient	NOUN
gra-1922	17	6	met	meet	VERB
gra-1922	17	7	the	the	DET
gra-1922	17	8	inclusion	inclusion	NOUN
gra-1922	17	9	criteria	criterion	NOUN
gra-1922	17	10	and	and	CCONJ
gra-1922	17	11	thus	thus	ADV
gra-1922	17	12	were	be	AUX
gra-1922	17	13	included	include	VERB
gra-1922	17	14	in	in	ADP
gra-1922	17	15	the	the	DET
gra-1922	17	16	study	study	NOUN
gra-1922	17	17	.	.	PUNCT
gra-1922	18	1	after	after	ADP
gra-1922	18	2	obtaining	obtain	VERB
gra-1922	18	3	ethical	ethical	ADJ
gra-1922	18	4	clearance	clearance	NOUN
gra-1922	18	5	and	and	CCONJ
gra-1922	18	6	consent	consent	NOUN
gra-1922	18	7	from	from	ADP
gra-1922	18	8	study	study	NOUN
gra-1922	18	9	participants	participant	NOUN
gra-1922	18	10	,	,	PUNCT
gra-1922	18	11	all	all	DET
gra-1922	18	12	the	the	DET
gra-1922	18	13	included	include	VERB
gra-1922	18	14	patients	patient	NOUN
gra-1922	18	15	were	be	AUX
gra-1922	18	16	randomly	randomly	ADV
gra-1922	18	17	divided	divide	VERB
gra-1922	18	18	into	into	ADP
gra-1922	18	19	2	2	NUM
gra-1922	18	20	groups	group	NOUN
gra-1922	18	21	using	use	VERB
gra-1922	18	22	random	random	ADJ
gra-1922	18	23	number	number	NOUN
gra-1922	18	24	tables	table	NOUN
gra-1922	18	25	.	.	PUNCT
gra-1922	19	1	patients	patient	NOUN
gra-1922	19	2	of	of	ADP
gra-1922	19	3	group	group	NOUN
gra-1922	19	4	1	1	NUM
gra-1922	19	5	received	receive	VERB
gra-1922	19	6	external	external	ADJ
gra-1922	19	7	beam	beam	NOUN
gra-1922	19	8	radiotherapy	radiotherapy	PROPN
gra-1922	19	9	2(ebrt	2(ebrt	PROPN
gra-1922	19	10	)	)	PUNCT
gra-1922	19	11	along	along	ADP
gra-1922	19	12	with	with	ADP
gra-1922	19	13	weekly	weekly	ADJ
gra-1922	19	14	cisplatin	cisplatin	NOUN
gra-1922	19	15	40	40	NUM
gra-1922	19	16	mg	mg	NUM
gra-1922	19	17	/	/	SYM
gra-1922	19	18	m	m	AUX
gra-1922	19	19	followed	follow	VERB
gra-1922	19	20	by	by	ADP
gra-1922	19	21	highdose	highdose	ADJ
gra-1922	19	22	rate	rate	NOUN
gra-1922	19	23	intracavitory	intracavitory	ADJ
gra-1922	19	24	brachytherapy	brachytherapy	NOUN
gra-1922	19	25	(	(	PUNCT
gra-1922	19	26	hdr	hdr	NOUN
gra-1922	19	27	icbt	icbt	ADJ
gra-1922	19	28	)	)	PUNCT
gra-1922	19	29	whereas	whereas	SCONJ
gra-1922	19	30	patients	patient	NOUN
gra-1922	19	31	of	of	ADP
gra-1922	19	32	group	group	NOUN
gra-1922	19	33	2	2	NUM
gra-1922	19	34	received	receive	VERB
gra-1922	19	35	ebrt	ebrt	ADJ
gra-1922	19	36	with	with	ADP
gra-1922	19	37	3	3	NUM
gra-1922	19	38	weekly	weekly	ADJ
gra-1922	19	39	cisplatin	cisplatin	NOUN
gra-1922	19	40	75	75	NUM
gra-1922	19	41	2mg	2mg	NOUN
gra-1922	19	42	/	/	SYM
gra-1922	19	43	m	m	AUX
gra-1922	19	44	followed	follow	VERB
gra-1922	19	45	by	by	ADP
gra-1922	19	46	hdr	hdr	NOUN
gra-1922	19	47	icbt	icbt	PROPN
gra-1922	19	48	.	.	PUNCT
gra-1922	20	1	radiotherapy	radiotherapy	NOUN
gra-1922	20	2	treatment	treatment	NOUN
gra-1922	20	3	protocol	protocol	NOUN
gra-1922	20	4	schedule	schedule	NOUN
gra-1922	20	5	in	in	ADP
gra-1922	20	6	both	both	DET
gra-1922	20	7	arms	arm	NOUN
gra-1922	20	8	included	include	VERB
gra-1922	20	9	external	external	ADJ
gra-1922	20	10	beam	beam	NOUN
gra-1922	20	11	radiotherapy	radiotherapy	NOUN
gra-1922	20	12	delivered	deliver	VERB
gra-1922	20	13	by	by	ADP
gra-1922	20	14	co60	co60	PROPN
gra-1922	20	15	teletherapy	teletherapy	NOUN
gra-1922	20	16	machine	machine	NOUN
gra-1922	20	17	and	and	CCONJ
gra-1922	20	18	hdr	hdr	NOUN
gra-1922	20	19	brachytherapy	brachytherapy	NOUN
gra-1922	20	20	.	.	PUNCT
gra-1922	21	1	cases	case	NOUN
gra-1922	21	2	were	be	AUX
gra-1922	21	3	treated	treat	VERB
gra-1922	21	4	by	by	ADP
gra-1922	21	5	conventional	conventional	ADJ
gra-1922	21	6	radiotherapy	radiotherapy	NOUN
gra-1922	21	7	schedule	schedule	NOUN
gra-1922	21	8	as	as	SCONJ
gra-1922	21	9	follows	follow	VERB
gra-1922	21	10	:	:	PUNCT
gra-1922	21	11	ebrt	ebrt	ADJ
gra-1922	21	12	=	=	SYM
gra-1922	21	13	5000	5000	NUM
gra-1922	21	14	cgy	cgy	NOUN
gra-1922	21	15	;	;	PUNCT
gra-1922	21	16	hdr	hdr	NOUN
gra-1922	21	17	icbt	icbt	ADJ
gra-1922	21	18	=	=	SYM
gra-1922	21	19	700	700	NUM
gra-1922	21	20	cgy	cgy	ADV
gra-1922	21	21	x	x	SYM
gra-1922	21	22	3	3	NUM
gra-1922	21	23	#	#	NOUN
gra-1922	21	24	point	point	NOUN
gra-1922	21	25	a	a	PRON
gra-1922	21	26	;	;	PUNCT
gra-1922	22	1	total	total	ADJ
gra-1922	22	2	dose	dose	NOUN
gra-1922	22	3	=	=	SYM
gra-1922	22	4	8000	8000	NUM
gra-1922	22	5	cgy	cgy	NOUN
gra-1922	22	6	.	.	PUNCT
gra-1922	22	7	ebrt	ebrt	PROPN
gra-1922	22	8	was	be	AUX
gra-1922	22	9	given	give	VERB
gra-1922	22	10	5	5	NUM
gra-1922	22	11	days	day	NOUN
gra-1922	22	12	a	a	DET
gra-1922	22	13	week	week	NOUN
gra-1922	22	14	with	with	ADP
gra-1922	22	15	total	total	ADJ
gra-1922	22	16	duration	duration	NOUN
gra-1922	22	17	of	of	ADP
gra-1922	22	18	35	35	NUM
gra-1922	22	19	days	day	NOUN
gra-1922	22	20	and	and	CCONJ
gra-1922	22	21	after	after	ADP
gra-1922	22	22	completion	completion	NOUN
gra-1922	22	23	of	of	ADP
gra-1922	22	24	ebrt	ebrt	ADJ
gra-1922	22	25	3	3	NUM
gra-1922	22	26	fraction	fraction	NOUN
gra-1922	22	27	of	of	ADP
gra-1922	22	28	weekly	weekly	ADJ
gra-1922	22	29	icrt	icrt	NOUN
gra-1922	22	30	was	be	AUX
gra-1922	22	31	given	give	VERB
gra-1922	22	32	.	.	PUNCT
gra-1922	23	1	portals	portal	NOUN
gra-1922	23	2	for	for	ADP
gra-1922	23	3	ebrt	ebrt	NOUN
gra-1922	23	4	of	of	ADP
gra-1922	23	5	pelvis	pelvis	NOUN
gra-1922	23	6	:	:	PUNCT
gra-1922	23	7	parallel	parallel	ADJ
gra-1922	23	8	opposed	oppose	VERB
gra-1922	23	9	(	(	PUNCT
gra-1922	23	10	anterior	anterior	ADJ
gra-1922	23	11	posterior	posterior	ADJ
gra-1922	23	12	elds	eld	NOUN
gra-1922	23	13	)	)	PUNCT
gra-1922	23	14	/four	/four	PUNCT
gra-1922	23	15	eld	eld	PROPN
gra-1922	23	16	box	box	NOUN
gra-1922	23	17	technique	technique	NOUN
gra-1922	23	18	.	.	PUNCT
gra-1922	24	1	radiation	radiation	NOUN
gra-1922	24	2	was	be	AUX
gra-1922	24	3	delivered	deliver	VERB
gra-1922	24	4	by	by	ADP
gra-1922	24	5	conventional	conventional	ADJ
gra-1922	24	6	fractionation	fractionation	NOUN
gra-1922	24	7	to	to	ADP
gra-1922	24	8	a	a	DET
gra-1922	24	9	total	total	ADJ
gra-1922	24	10	dose	dose	NOUN
gra-1922	24	11	of	of	ADP
gra-1922	24	12	46–50	46–50	NUM
gra-1922	24	13	gy	gy	VERB
gra-1922	24	14	at	at	ADP
gra-1922	24	15	the	the	DET
gra-1922	24	16	rate	rate	NOUN
gra-1922	24	17	of	of	ADP
gra-1922	24	18	2	2	NUM
gra-1922	24	19	gy	gy	NOUN
gra-1922	24	20	per	per	ADP
gra-1922	24	21	fraction	fraction	NOUN
gra-1922	24	22	,	,	PUNCT
gra-1922	24	23	1	1	NUM
gra-1922	24	24	fraction	fraction	NOUN
gra-1922	24	25	per	per	ADP
gra-1922	24	26	day	day	NOUN
gra-1922	24	27	and	and	CCONJ
gra-1922	24	28	5	5	NUM
gra-1922	24	29	fractions	fraction	NOUN
gra-1922	24	30	per	per	ADP
gra-1922	24	31	week	week	NOUN
gra-1922	24	32	in	in	ADP
gra-1922	24	33	23–25	23–25	NUM
gra-1922	24	34	fractions	fraction	NOUN
gra-1922	24	35	over	over	ADP
gra-1922	24	36	a	a	DET
gra-1922	24	37	period	period	NOUN
gra-1922	24	38	of	of	ADP
gra-1922	24	39	5–6	5–6	NUM
gra-1922	24	40	weeks	week	NOUN
gra-1922	24	41	.	.	PUNCT
gra-1922	25	1	cisplatin	cisplatin	NOUN
gra-1922	25	2	was	be	AUX
gra-1922	25	3	given	give	VERB
gra-1922	25	4	concurrently	concurrently	ADV
gra-1922	25	5	with	with	ADP
gra-1922	25	6	ebrt	ebrt	ADJ
gra-1922	25	7	once	once	ADV
gra-1922	25	8	weekly	weekly	ADJ
gra-1922	25	9	(	(	PUNCT
gra-1922	25	10	40	40	NUM
gra-1922	25	11	2mg	2mg	NOUN
gra-1922	25	12	/	/	SYM
gra-1922	25	13	m	m	NOUN
gra-1922	25	14	)	)	PUNCT
gra-1922	25	15	for	for	ADP
gra-1922	25	16	a	a	DET
gra-1922	25	17	total	total	NOUN
gra-1922	25	18	of	of	ADP
gra-1922	25	19	ve	ve	PROPN
gra-1922	25	20	cycles	cycle	NOUN
gra-1922	25	21	in	in	ADP
gra-1922	25	22	group	group	NOUN
gra-1922	25	23	1	1	NUM
gra-1922	25	24	and	and	CCONJ
gra-1922	25	25	once	once	ADV
gra-1922	25	26	in	in	ADP
gra-1922	25	27	3	3	NUM
gra-1922	25	28	weeks	week	NOUN
gra-1922	25	29	2(75	2(75	NUM
gra-1922	25	30	mg	mg	PROPN
gra-1922	25	31	/	/	SYM
gra-1922	25	32	m	m	PROPN
gra-1922	25	33	)	)	PUNCT
gra-1922	25	34	for	for	ADP
gra-1922	25	35	a	a	DET
gra-1922	25	36	total	total	NOUN
gra-1922	25	37	of	of	ADP
gra-1922	25	38	two	two	NUM
gra-1922	25	39	cycles	cycle	NOUN
gra-1922	25	40	in	in	ADP
gra-1922	25	41	group	group	PROPN
gra-1922	25	42	b	b	PROPN
gra-1922	25	43	during	during	ADP
gra-1922	25	44	the	the	DET
gra-1922	25	45	course	course	NOUN
gra-1922	25	46	of	of	ADP
gra-1922	25	47	ebrt	ebrt	ADJ
gra-1922	25	48	.	.	PUNCT
gra-1922	26	1	premedication	premedication	NOUN
gra-1922	26	2	in	in	ADP
gra-1922	26	3	both	both	CCONJ
gra-1922	26	4	the	the	DET
gra-1922	26	5	groups	group	NOUN
gra-1922	26	6	consists	consist	VERB
gra-1922	26	7	of	of	ADP
gra-1922	26	8	dexamethasone	dexamethasone	NOUN
gra-1922	26	9	8	8	NUM
gra-1922	26	10	mg	mg	NUM
gra-1922	26	11	iv	iv	NUM
gra-1922	26	12	,	,	PUNCT
gra-1922	26	13	ranitidine	ranitidine	NOUN
gra-1922	26	14	50	50	NUM
gra-1922	26	15	mg	mg	NOUN
gra-1922	26	16	iv	iv	NUM
gra-1922	26	17	and	and	CCONJ
gra-1922	26	18	a	a	DET
gra-1922	26	19	5ht3receptor	5ht3receptor	NUM
gra-1922	26	20	antagonist	antagonist	NOUN
gra-1922	26	21	as	as	ADP
gra-1922	26	22	antiemetic	antiemetic	ADJ
gra-1922	26	23	with	with	ADP
gra-1922	26	24	hydration	hydration	NOUN
gra-1922	26	25	for	for	ADP
gra-1922	26	26	two	two	NUM
gra-1922	26	27	hours	hour	NOUN
gra-1922	26	28	before	before	ADV
gra-1922	26	29	and	and	CCONJ
gra-1922	26	30	after	after	ADP
gra-1922	26	31	chemotherapy	chemotherapy	NOUN
gra-1922	26	32	with	with	ADP
gra-1922	26	33	d5	d5	NOUN
gra-1922	26	34	-	-	PUNCT
gra-1922	26	35	ns	ns	PROPN
gra-1922	26	36	at	at	ADP
gra-1922	26	37	150	150	NUM
gra-1922	26	38	cc	cc	NOUN
gra-1922	26	39	/	/	SYM
gra-1922	26	40	hr	hr	NOUN
gra-1922	26	41	.	.	PUNCT
gra-1922	27	1	after	after	ADP
gra-1922	27	2	chemotherapy	chemotherapy	NOUN
gra-1922	27	3	,	,	PUNCT
gra-1922	27	4	patients	patient	NOUN
gra-1922	27	5	in	in	ADP
gra-1922	27	6	both	both	CCONJ
gra-1922	27	7	the	the	DET
gra-1922	27	8	groups	group	NOUN
gra-1922	27	9	were	be	AUX
gra-1922	27	10	given	give	VERB
gra-1922	27	11	2	2	NUM
gra-1922	27	12	ampoules	ampoule	NOUN
gra-1922	27	13	(	(	PUNCT
gra-1922	27	14	300	300	NUM
gra-1922	27	15	mg	mg	NOUN
gra-1922	27	16	)	)	PUNCT
gra-1922	27	17	potassium	potassium	NOUN
gra-1922	27	18	chloride	chloride	NOUN
gra-1922	27	19	in	in	ADP
gra-1922	27	20	500	500	NUM
gra-1922	27	21	ml	ml	NOUN
gra-1922	27	22	of	of	ADP
gra-1922	27	23	0.9	0.9	NUM
gra-1922	27	24	%	%	NOUN
gra-1922	27	25	ns	ns	NUM
gra-1922	27	26	over	over	ADP
gra-1922	27	27	1	1	NUM
gra-1922	27	28	h	h	NOUN
gra-1922	27	29	followed	follow	VERB
gra-1922	27	30	by	by	ADP
gra-1922	27	31	2	2	NUM
gra-1922	27	32	ampoules	ampoule	NOUN
gra-1922	27	33	of	of	ADP
gra-1922	27	34	50	50	NUM
gra-1922	27	35	%	%	NOUN
gra-1922	27	36	w	w	NOUN
gra-1922	27	37	/	/	SYM
gra-1922	27	38	v	v	NOUN
gra-1922	27	39	magnesium	magnesium	NOUN
gra-1922	27	40	sulphate	sulphate	NOUN
gra-1922	27	41	in	in	ADP
gra-1922	27	42	500	500	NUM
gra-1922	27	43	ml	ml	NOUN
gra-1922	27	44	of	of	ADP
gra-1922	27	45	5	5	NUM
gra-1922	27	46	%	%	NOUN
gra-1922	27	47	dextrose	dextrose	NOUN
gra-1922	27	48	over	over	ADP
gra-1922	27	49	1	1	NUM
gra-1922	27	50	h.	h.	NOUN
gra-1922	27	51	also	also	ADV
gra-1922	27	52	hydration	hydration	NOUN
gra-1922	27	53	was	be	AUX
gra-1922	27	54	concurrent	concurrent	ADJ
gra-1922	27	55	weekly	weekly	ADJ
gra-1922	27	56	cisplatin	cisplatin	NOUN
gra-1922	27	57	vs	vs	ADP
gra-1922	27	58	triweekly	triweekly	ADJ
gra-1922	27	59	cisplatin	cisplatin	NOUN
gra-1922	27	60	with	with	ADP
gra-1922	27	61	radiotherapy	radiotherapy	NOUN
gra-1922	27	62	for	for	ADP
gra-1922	27	63	treatment	treatment	NOUN
gra-1922	27	64	of	of	ADP
gra-1922	27	65	locally	locally	ADV
gra-1922	27	66	advanced	advanced	ADJ
gra-1922	27	67	cervical	cervical	ADJ
gra-1922	27	68	cancer	cancer	NOUN
gra-1922	27	69	original	original	ADJ
gra-1922	27	70	research	research	NOUN
gra-1922	27	71	paper	paper	NOUN
gra-1922	27	72	dr	dr	PROPN
gra-1922	27	73	ajit	ajit	PROPN
gra-1922	27	74	kumar	kumar	PROPN
gra-1922	27	75	sanjay	sanjay	PROPN
gra-1922	27	76	gandhi	gandhi	PROPN
gra-1922	27	77	memorial	memorial	ADJ
gra-1922	27	78	hospital	hospital	NOUN
gra-1922	27	79	,	,	PUNCT
gra-1922	27	80	shyam	shyam	PROPN
gra-1922	27	81	shah	shah	PROPN
gra-1922	27	82	medical	medical	PROPN
gra-1922	27	83	college	college	PROPN
gra-1922	27	84	rewa	rewa	PROPN
gra-1922	27	85	.	.	PUNCT
gra-1922	28	1	x	x	PUNCT
gra-1922	28	2	55gjra	55gjra	NUM
gra-1922	28	3	global	global	ADJ
gra-1922	28	4	journal	journal	PROPN
gra-1922	28	5	for	for	ADP
gra-1922	28	6	research	research	NOUN
gra-1922	28	7	analysis	analysis	NOUN
gra-1922	28	8	medical	medical	ADJ
gra-1922	28	9	science	science	NOUN
gra-1922	28	10	introductionthe	introductionthe	DET
gra-1922	28	11	present	present	ADJ
gra-1922	28	12	study	study	NOUN
gra-1922	28	13	was	be	AUX
gra-1922	28	14	conducted	conduct	VERB
gra-1922	28	15	to	to	PART
gra-1922	28	16	assess	assess	VERB
gra-1922	28	17	the	the	DET
gra-1922	28	18	efcacy	efcacy	NOUN
gra-1922	28	19	and	and	CCONJ
gra-1922	28	20	toxicity	toxicity	NOUN
gra-1922	28	21	prole	prole	PROPN
gra-1922	28	22	of	of	ADP
gra-1922	28	23	concurrent	concurrent	ADJ
gra-1922	28	24	weekly	weekly	ADJ
gra-1922	28	25	cisplatin	cisplatin	NOUN
gra-1922	28	26	dosing	dose	VERB
gra-1922	28	27	as	as	SCONJ
gra-1922	28	28	compared	compare	VERB
gra-1922	28	29	to	to	ADP
gra-1922	28	30	3	3	NUM
gra-1922	28	31	weekly	weekly	ADJ
gra-1922	28	32	cisplatin	cisplatin	NOUN
gra-1922	28	33	with	with	ADP
gra-1922	28	34	radiotherapy	radiotherapy	NOUN
gra-1922	28	35	in	in	ADP
gra-1922	28	36	patients	patient	NOUN
gra-1922	28	37	of	of	ADP
gra-1922	28	38	cervical	cervical	ADJ
gra-1922	28	39	cancer	cancer	NOUN
gra-1922	28	40	and	and	CCONJ
gra-1922	28	41	also	also	ADV
gra-1922	28	42	to	to	PART
gra-1922	28	43	evaluate	evaluate	VERB
gra-1922	28	44	the	the	DET
gra-1922	28	45	compliance	compliance	NOUN
gra-1922	28	46	among	among	ADP
gra-1922	28	47	them	they	PRON
gra-1922	28	48	.	.	PUNCT
gra-1922	29	1	methodologythis	methodologythis	PRON
gra-1922	29	2	was	be	AUX
gra-1922	29	3	prospective	prospective	ADJ
gra-1922	29	4	randomized	randomized	ADJ
gra-1922	29	5	comparative	comparative	ADJ
gra-1922	29	6	study	study	NOUN
gra-1922	29	7	at	at	ADP
gra-1922	29	8	tertiary	tertiary	ADJ
gra-1922	29	9	centreon	centreon	ADJ
gra-1922	29	10	patients	patient	NOUN
gra-1922	29	11	of	of	ADP
gra-1922	29	12	locally	locally	ADV
gra-1922	29	13	advanced	advanced	ADJ
gra-1922	29	14	cervical	cervical	ADJ
gra-1922	29	15	cancer	cancer	NOUN
gra-1922	29	16	.	.	PUNCT
gra-1922	30	1	patients	patient	NOUN
gra-1922	30	2	were	be	AUX
gra-1922	30	3	randomly	randomly	ADV
gra-1922	30	4	divided	divide	VERB
gra-1922	30	5	into	into	ADP
gra-1922	30	6	2	2	NUM
gra-1922	30	7	groups	group	NOUN
gra-1922	30	8	and	and	CCONJ
gra-1922	30	9	patients	patient	NOUN
gra-1922	30	10	of	of	ADP
gra-1922	30	11	group	group	NOUN
gra-1922	30	12	1	1	NUM
gra-1922	30	13	received	receive	VERB
gra-1922	30	14	ebrt	ebrt	ADJ
gra-1922	30	15	with	with	ADP
gra-1922	30	16	weekly	weekly	ADJ
gra-1922	30	17	cisplatin	cisplatin	NOUN
gra-1922	30	18	whereas	whereas	SCONJ
gra-1922	30	19	patients	patient	NOUN
gra-1922	30	20	of	of	ADP
gra-1922	30	21	group	group	NOUN
gra-1922	30	22	2	2	NUM
gra-1922	30	23	received	receive	VERB
gra-1922	30	24	ebrt	ebrt	ADJ
gra-1922	30	25	with	with	ADP
gra-1922	30	26	3	3	NUM
gra-1922	30	27	weekly	weekly	ADJ
gra-1922	30	28	cisplatin	cisplatin	NOUN
gra-1922	30	29	.	.	PUNCT
gra-1922	31	1	all	all	DET
gra-1922	31	2	the	the	DET
gra-1922	31	3	patients	patient	NOUN
gra-1922	31	4	were	be	AUX
gra-1922	31	5	followed	follow	VERB
gra-1922	31	6	up	up	ADP
gra-1922	31	7	for	for	ADP
gra-1922	31	8	assessment	assessment	NOUN
gra-1922	31	9	of	of	ADP
gra-1922	31	10	compliance	compliance	NOUN
gra-1922	31	11	,	,	PUNCT
gra-1922	31	12	acute	acute	ADJ
gra-1922	31	13	toxicities	toxicity	NOUN
gra-1922	31	14	and	and	CCONJ
gra-1922	31	15	treatment	treatment	NOUN
gra-1922	31	16	response	response	NOUN
gra-1922	31	17	.	.	PUNCT
gra-1922	32	1	resultsthe	resultsthe	PROPN
gra-1922	32	2	study	study	PROPN
gra-1922	32	3	included	include	VERB
gra-1922	32	4	80	80	NUM
gra-1922	32	5	patients	patient	NOUN
gra-1922	32	6	which	which	PRON
gra-1922	32	7	were	be	AUX
gra-1922	32	8	randomized	randomize	VERB
gra-1922	32	9	into	into	ADP
gra-1922	32	10	2	2	NUM
gra-1922	32	11	groups	group	NOUN
gra-1922	32	12	.	.	PUNCT
gra-1922	33	1	the	the	DET
gra-1922	33	2	population	population	NOUN
gra-1922	33	3	in	in	ADP
gra-1922	33	4	two	two	NUM
gra-1922	33	5	groups	group	NOUN
gra-1922	33	6	was	be	AUX
gra-1922	33	7	comparable	comparable	ADJ
gra-1922	33	8	in	in	ADP
gra-1922	33	9	baseline	baseline	ADJ
gra-1922	33	10	characteristics	characteristic	NOUN
gra-1922	33	11	.	.	PUNCT
gra-1922	34	1	no	no	DET
gra-1922	34	2	statistically	statistically	ADV
gra-1922	34	3	signicant	signicant	ADJ
gra-1922	34	4	difference	difference	NOUN
gra-1922	34	5	in	in	ADP
gra-1922	34	6	occurrence	occurrence	NOUN
gra-1922	34	7	of	of	ADP
gra-1922	34	8	acute	acute	ADJ
gra-1922	34	9	toxicities	toxicity	NOUN
gra-1922	34	10	between	between	ADP
gra-1922	34	11	the	the	DET
gra-1922	34	12	participants	participant	NOUN
gra-1922	34	13	of	of	ADP
gra-1922	34	14	two	two	NUM
gra-1922	34	15	groups	group	NOUN
gra-1922	34	16	was	be	AUX
gra-1922	34	17	observed	observe	VERB
gra-1922	34	18	(	(	PUNCT
gra-1922	34	19	p>0.05	p>0.05	NOUN
gra-1922	34	20	)	)	PUNCT
gra-1922	34	21	.	.	PUNCT
gra-1922	35	1	clinically	clinically	ADV
gra-1922	35	2	,	,	PUNCT
gra-1922	35	3	complete	complete	ADJ
gra-1922	35	4	response	response	NOUN
gra-1922	35	5	was	be	AUX
gra-1922	35	6	noted	note	VERB
gra-1922	35	7	in	in	ADP
gra-1922	35	8	82.5	82.5	NUM
gra-1922	35	9	%	%	NOUN
gra-1922	35	10	and	and	CCONJ
gra-1922	35	11	90	90	NUM
gra-1922	35	12	%	%	NOUN
gra-1922	35	13	patients	patient	NOUN
gra-1922	35	14	in	in	ADP
gra-1922	35	15	group	group	NOUN
gra-1922	35	16	1	1	NUM
gra-1922	35	17	and	and	CCONJ
gra-1922	35	18	group	group	NOUN
gra-1922	35	19	2	2	NUM
gra-1922	35	20	respectively	respectively	ADV
gra-1922	35	21	.	.	PUNCT
gra-1922	36	1	however	however	ADV
gra-1922	36	2	the	the	DET
gra-1922	36	3	observed	observed	ADJ
gra-1922	36	4	difference	difference	NOUN
gra-1922	36	5	in	in	ADP
gra-1922	36	6	response	response	NOUN
gra-1922	36	7	was	be	AUX
gra-1922	36	8	not	not	PART
gra-1922	36	9	statistically	statistically	ADV
gra-1922	36	10	signicant	signicant	ADJ
gra-1922	36	11	(	(	PUNCT
gra-1922	36	12	p>0.05	p>0.05	PROPN
gra-1922	36	13	)	)	PUNCT
gra-1922	36	14	.	.	PUNCT
gra-1922	37	1	conclusionthe	conclusionthe	PROPN
gra-1922	37	2	present	present	ADJ
gra-1922	37	3	study	study	NOUN
gra-1922	37	4	documented	document	VERB
gra-1922	37	5	similar	similar	ADJ
gra-1922	37	6	response	response	NOUN
gra-1922	37	7	and	and	CCONJ
gra-1922	37	8	toxicity	toxicity	NOUN
gra-1922	37	9	prole	prole	PROPN
gra-1922	37	10	of	of	ADP
gra-1922	37	11	both	both	CCONJ
gra-1922	37	12	the	the	DET
gra-1922	37	13	regimens	regimen	NOUN
gra-1922	37	14	and	and	CCONJ
gra-1922	37	15	thus	thus	ADV
gra-1922	37	16	concurrent	concurrent	ADJ
gra-1922	37	17	weekly	weekly	NOUN
gra-1922	37	18	or	or	CCONJ
gra-1922	37	19	3	3	NUM
gra-1922	37	20	weekly	weekly	ADJ
gra-1922	37	21	cisplatin	cisplatin	NOUN
gra-1922	37	22	along	along	ADP
gra-1922	37	23	with	with	ADP
gra-1922	37	24	radiotherapy	radiotherapy	NOUN
gra-1922	37	25	can	can	AUX
gra-1922	37	26	be	be	AUX
gra-1922	37	27	used	use	VERB
gra-1922	37	28	with	with	ADP
gra-1922	37	29	equal	equal	ADJ
gra-1922	37	30	effectiveness	effectiveness	NOUN
gra-1922	37	31	in	in	ADP
gra-1922	37	32	the	the	DET
gra-1922	37	33	treatment	treatment	NOUN
gra-1922	37	34	of	of	ADP
gra-1922	37	35	cervical	cervical	ADJ
gra-1922	37	36	cancer	cancer	NOUN
gra-1922	37	37	.	.	PUNCT
gra-1922	38	1	abstract	abstract	ADJ
gra-1922	38	2	keywords	keyword	NOUN
gra-1922	38	3	:	:	PUNCT
gra-1922	38	4	concurrent	concurrent	ADJ
gra-1922	38	5	cisplatin	cisplatin	NOUN
gra-1922	38	6	,	,	PUNCT
gra-1922	38	7	weekly	weekly	ADJ
gra-1922	38	8	,	,	PUNCT
gra-1922	38	9	triweekly	triweekly	NOUN
gra-1922	38	10	,	,	PUNCT
gra-1922	38	11	central	central	ADJ
gra-1922	38	12	india	india	PROPN
gra-1922	38	13	,	,	PUNCT
gra-1922	38	14	cervical	cervical	ADJ
gra-1922	38	15	cancer	cancer	NOUN
gra-1922	38	16	volume-9	volume-9	PROPN
gra-1922	38	17	,	,	PUNCT
gra-1922	38	18	issue-2	issue-2	PROPN
gra-1922	38	19	,	,	PUNCT
gra-1922	38	20	february-2020	february-2020	VERB
gra-1922	38	21	•	•	NUM
gra-1922	38	22	print	print	NOUN
gra-1922	38	23	issn	issn	PROPN
gra-1922	38	24	no	no	NOUN
gra-1922	38	25	.	.	PROPN
gra-1922	38	26	2277	2277	NUM
gra-1922	38	27	8160	8160	NUM
gra-1922	38	28	•	•	NOUN
gra-1922	38	29	doi	doi	NOUN
gra-1922	38	30	:	:	PUNCT
gra-1922	38	31	10.36106	10.36106	NUM
gra-1922	38	32	/	/	SYM
gra-1922	38	33	gjra	gjra	PROPN
gra-1922	38	34	dr	dr	PROPN
gra-1922	38	35	aradhna	aradhna	PROPN
gra-1922	38	36	tripathi	tripathi	PROPN
gra-1922	38	37	*	*	PROPN
gra-1922	38	38	sanjay	sanjay	PROPN
gra-1922	38	39	gandhi	gandhi	PROPN
gra-1922	38	40	memorial	memorial	ADJ
gra-1922	38	41	hospital	hospital	NOUN
gra-1922	38	42	,	,	PUNCT
gra-1922	38	43	shyam	shyam	PROPN
gra-1922	38	44	shah	shah	PROPN
gra-1922	38	45	medical	medical	PROPN
gra-1922	38	46	college	college	PROPN
gra-1922	38	47	rewa	rewa	PROPN
gra-1922	38	48	.	.	PUNCT
gra-1922	39	1	*	*	PUNCT
gra-1922	39	2	corresponding	correspond	VERB
gra-1922	39	3	author	author	NOUN
gra-1922	39	4	56	56	NUM
gra-1922	39	5	x	x	NOUN
gra-1922	39	6	gjra	gjra	ADJ
gra-1922	39	7	global	global	ADJ
gra-1922	39	8	journal	journal	PROPN
gra-1922	39	9	for	for	ADP
gra-1922	39	10	research	research	NOUN
gra-1922	39	11	analysis	analysis	NOUN
gra-1922	39	12	maintained	maintain	VERB
gra-1922	39	13	in	in	ADP
gra-1922	39	14	post	post	NOUN
gra-1922	39	15	chemotherapy	chemotherapy	NOUN
gra-1922	39	16	phase	phase	NOUN
gra-1922	39	17	.	.	PUNCT
gra-1922	40	1	all	all	DET
gra-1922	40	2	patients	patient	NOUN
gra-1922	40	3	were	be	AUX
gra-1922	40	4	enquired	enquire	VERB
gra-1922	40	5	about	about	ADP
gra-1922	40	6	sociodemographic	sociodemographic	ADJ
gra-1922	40	7	details	detail	NOUN
gra-1922	40	8	and	and	CCONJ
gra-1922	40	9	were	be	AUX
gra-1922	40	10	subjected	subject	VERB
gra-1922	40	11	to	to	ADP
gra-1922	40	12	thorough	thorough	ADJ
gra-1922	40	13	general	general	ADJ
gra-1922	40	14	examination	examination	NOUN
gra-1922	40	15	.	.	PUNCT
gra-1922	41	1	all	all	DET
gra-1922	41	2	patients	patient	NOUN
gra-1922	41	3	were	be	AUX
gra-1922	41	4	subjected	subject	VERB
gra-1922	41	5	to	to	PART
gra-1922	41	6	complete	complete	VERB
gra-1922	41	7	blood	blood	NOUN
gra-1922	41	8	examination	examination	NOUN
gra-1922	41	9	,	,	PUNCT
gra-1922	41	10	rbs	rbs	PROPN
gra-1922	41	11	,	,	PUNCT
gra-1922	41	12	renal	renal	ADJ
gra-1922	41	13	function	function	NOUN
gra-1922	41	14	test	test	NOUN
gra-1922	41	15	,	,	PUNCT
gra-1922	41	16	liver	liver	NOUN
gra-1922	41	17	function	function	NOUN
gra-1922	41	18	test	test	NOUN
gra-1922	41	19	,	,	PUNCT
gra-1922	41	20	chest	chest	NOUN
gra-1922	41	21	x	x	NOUN
gra-1922	41	22	-	-	NOUN
gra-1922	41	23	ray	ray	NOUN
gra-1922	41	24	(	(	PUNCT
gra-1922	41	25	pa	pa	PROPN
gra-1922	41	26	view	view	PROPN
gra-1922	41	27	)	)	PUNCT
gra-1922	41	28	,	,	PUNCT
gra-1922	41	29	usg	usg	PROPN
gra-1922	41	30	abdomen	abdomen	PROPN
gra-1922	41	31	and	and	CCONJ
gra-1922	41	32	pelvis	pelvis	X
gra-1922	41	33	.	.	PUNCT
gra-1922	42	1	ct	ct	X
gra-1922	42	2	/	/	SYM
gra-1922	42	3	mri	mri	NOUN
gra-1922	42	4	abdomen	abdoman	NOUN
gra-1922	42	5	and	and	CCONJ
gra-1922	42	6	pelvis	pelvis	NOUN
gra-1922	42	7	was	be	AUX
gra-1922	42	8	conducted	conduct	VERB
gra-1922	42	9	when	when	SCONJ
gra-1922	42	10	required	require	VERB
gra-1922	42	11	.	.	PUNCT
gra-1922	43	1	follow	follow	VERB
gra-1922	43	2	up	up	ADP
gra-1922	43	3	:	:	PUNCT
gra-1922	43	4	all	all	DET
gra-1922	43	5	the	the	DET
gra-1922	43	6	patients	patient	NOUN
gra-1922	43	7	were	be	AUX
gra-1922	43	8	followed	follow	VERB
gra-1922	43	9	up	up	ADP
gra-1922	43	10	at	at	ADP
gra-1922	43	11	6	6	NUM
gra-1922	43	12	weeks	week	NOUN
gra-1922	43	13	after	after	ADP
gra-1922	43	14	completion	completion	NOUN
gra-1922	43	15	of	of	ADP
gra-1922	43	16	treatment	treatment	NOUN
gra-1922	43	17	and	and	CCONJ
gra-1922	43	18	then	then	ADV
gra-1922	43	19	they	they	PRON
gra-1922	43	20	were	be	AUX
gra-1922	43	21	followed	follow	VERB
gra-1922	43	22	up	up	ADP
gra-1922	43	23	every	every	DET
gra-1922	43	24	1	1	NUM
gra-1922	43	25	month	month	NOUN
gra-1922	43	26	for	for	ADP
gra-1922	43	27	rst	rst	PROPN
gra-1922	43	28	3	3	NUM
gra-1922	43	29	months	month	NOUN
gra-1922	43	30	,	,	PUNCT
gra-1922	43	31	every	every	DET
gra-1922	43	32	3	3	NUM
gra-1922	43	33	monthly	monthly	ADV
gra-1922	43	34	for	for	ADP
gra-1922	43	35	9	9	NUM
gra-1922	43	36	months	month	NOUN
gra-1922	43	37	then	then	ADV
gra-1922	43	38	for	for	ADP
gra-1922	43	39	every	every	DET
gra-1922	43	40	4	4	NUM
gra-1922	43	41	months	month	NOUN
gra-1922	43	42	for	for	ADP
gra-1922	43	43	2	2	NUM
gra-1922	43	44	years	year	NOUN
gra-1922	43	45	.	.	PUNCT
gra-1922	44	1	follow	follow	VERB
gra-1922	44	2	-	-	PUNCT
gra-1922	44	3	up	up	ADP
gra-1922	44	4	procedures	procedure	NOUN
gra-1922	44	5	include	include	VERB
gra-1922	44	6	general	general	ADJ
gra-1922	44	7	,	,	PUNCT
gra-1922	44	8	systemic	systemic	ADJ
gra-1922	44	9	and	and	CCONJ
gra-1922	44	10	pelvic	pelvic	ADJ
gra-1922	44	11	examination	examination	NOUN
gra-1922	44	12	,	,	PUNCT
gra-1922	44	13	palpation	palpation	NOUN
gra-1922	44	14	of	of	ADP
gra-1922	44	15	inguinal	inguinal	ADJ
gra-1922	44	16	and	and	CCONJ
gra-1922	44	17	supraclavicular	supraclavicular	ADJ
gra-1922	44	18	nodes	node	NOUN
gra-1922	44	19	.	.	PUNCT
gra-1922	45	1	imaging	imaging	NOUN
gra-1922	45	2	studies	study	NOUN
gra-1922	45	3	,	,	PUNCT
gra-1922	45	4	such	such	ADJ
gra-1922	45	5	as	as	ADP
gra-1922	45	6	radiograph	radiograph	NOUN
gra-1922	45	7	,	,	PUNCT
gra-1922	45	8	computed	compute	VERB
gra-1922	45	9	tomography	tomography	NOUN
gra-1922	45	10	,	,	PUNCT
gra-1922	45	11	ultrasonography	ultrasonography	NOUN
gra-1922	45	12	and	and	CCONJ
gra-1922	45	13	bone	bone	NOUN
gra-1922	45	14	scan	scan	NOUN
gra-1922	45	15	were	be	AUX
gra-1922	45	16	done	do	VERB
gra-1922	45	17	when	when	SCONJ
gra-1922	45	18	required	require	VERB
gra-1922	45	19	.	.	PUNCT
gra-1922	46	1	statistical	statistical	ADJ
gra-1922	46	2	analysis	analysis	NOUN
gra-1922	46	3	the	the	DET
gra-1922	46	4	data	datum	NOUN
gra-1922	46	5	was	be	AUX
gra-1922	46	6	compiled	compile	VERB
gra-1922	46	7	using	use	VERB
gra-1922	46	8	msexcel	msexcel	NOUN
gra-1922	46	9	and	and	CCONJ
gra-1922	46	10	analysed	analyse	VERB
gra-1922	46	11	using	use	VERB
gra-1922	46	12	spss	spss	PROPN
gra-1922	46	13	software	software	NOUN
gra-1922	46	14	version	version	NOUN
gra-1922	46	15	20	20	NUM
gra-1922	46	16	(	(	PUNCT
gra-1922	46	17	ibm	ibm	PROPN
gra-1922	46	18	spss	spss	PROPN
gra-1922	46	19	statistics	statistic	NOUN
gra-1922	46	20	,	,	PUNCT
gra-1922	46	21	somers	somers	PROPN
gra-1922	46	22	ny	ny	PROPN
gra-1922	46	23	,	,	PUNCT
gra-1922	46	24	usa	usa	PROPN
gra-1922	46	25	)	)	PUNCT
gra-1922	46	26	.	.	PUNCT
gra-1922	47	1	frequencies	frequency	NOUN
gra-1922	47	2	and	and	CCONJ
gra-1922	47	3	percentages	percentage	NOUN
gra-1922	47	4	were	be	AUX
gra-1922	47	5	calculated	calculate	VERB
gra-1922	47	6	using	use	VERB
gra-1922	47	7	grouped	group	VERB
gra-1922	47	8	data	datum	NOUN
gra-1922	47	9	.	.	PUNCT
gra-1922	48	1	all	all	DET
gra-1922	48	2	the	the	DET
gra-1922	48	3	descriptive	descriptive	ADJ
gra-1922	48	4	data	datum	NOUN
gra-1922	48	5	was	be	AUX
gra-1922	48	6	represented	represent	VERB
gra-1922	48	7	as	as	ADP
gra-1922	48	8	mean	mean	NOUN
gra-1922	48	9	±	±	NUM
gra-1922	48	10	sd	sd	NOUN
gra-1922	48	11	.	.	PUNCT
gra-1922	49	1	student	student	NOUN
gra-1922	49	2	independent	independent	ADJ
gra-1922	49	3	'	'	PUNCT
gra-1922	49	4	t	t	NOUN
gra-1922	49	5	'	'	PUNCT
gra-1922	49	6	test	test	NOUN
gra-1922	49	7	was	be	AUX
gra-1922	49	8	used	use	VERB
gra-1922	49	9	to	to	PART
gra-1922	49	10	compare	compare	VERB
gra-1922	49	11	the	the	DET
gra-1922	49	12	means	mean	NOUN
gra-1922	49	13	of	of	ADP
gra-1922	49	14	different	different	ADJ
gra-1922	49	15	continuous	continuous	ADJ
gra-1922	49	16	variables	variable	NOUN
gra-1922	49	17	whereas	whereas	SCONJ
gra-1922	49	18	pearson	pearson	PROPN
gra-1922	49	19	's	's	PART
gra-1922	49	20	chi	chi	ADJ
gra-1922	49	21	-	-	PUNCT
gra-1922	49	22	square	square	ADJ
gra-1922	49	23	test	test	NOUN
gra-1922	49	24	was	be	AUX
gra-1922	49	25	applied	apply	VERB
gra-1922	49	26	to	to	PART
gra-1922	49	27	assess	assess	VERB
gra-1922	49	28	the	the	DET
gra-1922	49	29	association	association	NOUN
gra-1922	49	30	among	among	ADP
gra-1922	49	31	different	different	ADJ
gra-1922	49	32	categorical	categorical	ADJ
gra-1922	49	33	variables	variable	NOUN
gra-1922	49	34	.	.	PUNCT
gra-1922	50	1	p	p	X
gra-1922	50	2	<	<	X
gra-1922	50	3	0.05	0.05	NUM
gra-1922	50	4	was	be	AUX
gra-1922	50	5	taken	take	VERB
gra-1922	50	6	statistically	statistically	ADV
gra-1922	50	7	signicant	signicant	ADJ
gra-1922	50	8	.	.	PUNCT
gra-1922	51	1	results	result	VERB
gra-1922	51	2	the	the	DET
gra-1922	51	3	present	present	ADJ
gra-1922	51	4	study	study	NOUN
gra-1922	51	5	included	include	VERB
gra-1922	51	6	a	a	DET
gra-1922	51	7	total	total	NOUN
gra-1922	51	8	of	of	ADP
gra-1922	51	9	80	80	NUM
gra-1922	51	10	patients	patient	NOUN
gra-1922	51	11	diagnosed	diagnose	VERB
gra-1922	51	12	with	with	ADP
gra-1922	51	13	locally	locally	ADV
gra-1922	51	14	advance	advance	VERB
gra-1922	51	15	cervical	cervical	ADJ
gra-1922	51	16	cancer	cancer	NOUN
gra-1922	51	17	.	.	PUNCT
gra-1922	52	1	these	these	DET
gra-1922	52	2	patients	patient	NOUN
gra-1922	52	3	were	be	AUX
gra-1922	52	4	randomly	randomly	ADV
gra-1922	52	5	allocated	allocate	VERB
gra-1922	52	6	into	into	ADP
gra-1922	52	7	2	2	NUM
gra-1922	52	8	groups	group	NOUN
gra-1922	52	9	of	of	ADP
gra-1922	52	10	40	40	NUM
gra-1922	52	11	patients	patient	NOUN
gra-1922	52	12	each	each	PRON
gra-1922	52	13	.	.	PUNCT
gra-1922	53	1	patients	patient	NOUN
gra-1922	53	2	in	in	ADP
gra-1922	53	3	group	group	NOUN
gra-1922	53	4	1	1	NUM
gra-1922	53	5	received	receive	VERB
gra-1922	53	6	cisplatin	cisplatin	NOUN
gra-1922	53	7	concurrently	concurrently	ADV
gra-1922	53	8	with	with	ADP
gra-1922	53	9	ebrt	ebrt	ADJ
gra-1922	53	10	once	once	ADV
gra-1922	53	11	weekly	weekly	ADJ
gra-1922	53	12	(	(	PUNCT
gra-1922	53	13	40	40	NUM
gra-1922	53	14	mg	mg	PROPN
gra-1922	53	15	/	/	SYM
gra-1922	53	16	m2	m2	PROPN
gra-1922	53	17	)	)	PUNCT
gra-1922	53	18	for	for	ADP
gra-1922	53	19	a	a	DET
gra-1922	53	20	total	total	NOUN
gra-1922	53	21	of	of	ADP
gra-1922	53	22	ve	ve	PROPN
gra-1922	53	23	cycles	cycle	NOUN
gra-1922	53	24	whereas	whereas	SCONJ
gra-1922	53	25	patients	patient	NOUN
gra-1922	53	26	in	in	ADP
gra-1922	53	27	group	group	NOUN
gra-1922	53	28	2	2	NUM
gra-1922	53	29	received	receive	VERB
gra-1922	53	30	cisplatin	cisplatin	NOUN
gra-1922	53	31	once	once	ADV
gra-1922	53	32	in	in	ADP
gra-1922	53	33	3	3	NUM
gra-1922	53	34	weeks	week	NOUN
gra-1922	53	35	(	(	PUNCT
gra-1922	53	36	75	75	NUM
gra-1922	53	37	mg	mg	NUM
gra-1922	53	38	/	/	SYM
gra-1922	53	39	m2	m2	PROPN
gra-1922	53	40	)	)	PUNCT
gra-1922	53	41	for	for	ADP
gra-1922	53	42	a	a	DET
gra-1922	53	43	total	total	NOUN
gra-1922	53	44	of	of	ADP
gra-1922	53	45	two	two	NUM
gra-1922	53	46	cycles	cycle	NOUN
gra-1922	53	47	in	in	ADP
gra-1922	53	48	group	group	PROPN
gra-1922	53	49	b	b	PROPN
gra-1922	53	50	during	during	ADP
gra-1922	53	51	the	the	DET
gra-1922	53	52	course	course	NOUN
gra-1922	53	53	of	of	ADP
gra-1922	53	54	ebrt	ebrt	ADJ
gra-1922	53	55	.	.	PUNCT
gra-1922	54	1	table	table	NOUN
gra-1922	54	2	1distribution	1distribution	NUM
gra-1922	54	3	according	accord	VERB
gra-1922	54	4	to	to	ADP
gra-1922	54	5	baseline	baseline	PROPN
gra-1922	54	6	characteristics	characteristic	NOUN
gra-1922	54	7	above	above	ADP
gra-1922	54	8	table	table	NOUN
gra-1922	54	9	represents	represent	VERB
gra-1922	54	10	baseline	baseline	ADJ
gra-1922	54	11	characteristics	characteristic	NOUN
gra-1922	54	12	of	of	ADP
gra-1922	54	13	participants	participant	NOUN
gra-1922	54	14	of	of	ADP
gra-1922	54	15	two	two	NUM
gra-1922	54	16	groups	group	NOUN
gra-1922	54	17	.	.	PUNCT
gra-1922	55	1	the	the	DET
gra-1922	55	2	population	population	NOUN
gra-1922	55	3	in	in	ADP
gra-1922	55	4	two	two	NUM
gra-1922	55	5	groups	group	NOUN
gra-1922	55	6	was	be	AUX
gra-1922	55	7	comparable	comparable	ADJ
gra-1922	55	8	in	in	ADP
gra-1922	55	9	age	age	NOUN
gra-1922	55	10	composition	composition	NOUN
gra-1922	55	11	,	,	PUNCT
gra-1922	55	12	residence	residence	NOUN
gra-1922	55	13	,	,	PUNCT
gra-1922	55	14	ecog	ecog	VERB
gra-1922	55	15	status	status	NOUN
gra-1922	55	16	,	,	PUNCT
gra-1922	55	17	socioeconomic	socioeconomic	ADJ
gra-1922	55	18	status	status	NOUN
gra-1922	55	19	and	and	CCONJ
gra-1922	55	20	stage	stage	NOUN
gra-1922	55	21	of	of	ADP
gra-1922	55	22	cervical	cervical	ADJ
gra-1922	55	23	cancer	cancer	NOUN
gra-1922	55	24	.	.	PUNCT
gra-1922	56	1	table	table	NOUN
gra-1922	56	2	2distribution	2distribution	NUM
gra-1922	56	3	according	accord	VERB
gra-1922	56	4	to	to	ADP
gra-1922	56	5	chemotherapy	chemotherapy	NOUN
gra-1922	56	6	in	in	ADP
gra-1922	56	7	both	both	CCONJ
gra-1922	56	8	the	the	DET
gra-1922	56	9	groups	group	NOUN
gra-1922	56	10	patients	patient	NOUN
gra-1922	56	11	in	in	ADP
gra-1922	56	12	the	the	DET
gra-1922	56	13	group	group	NOUN
gra-1922	56	14	1	1	NUM
gra-1922	56	15	received	receive	VERB
gra-1922	56	16	a	a	DET
gra-1922	56	17	mean	mean	ADJ
gra-1922	56	18	dose	dose	NOUN
gra-1922	56	19	of	of	ADP
gra-1922	56	20	45.5	45.5	NUM
gra-1922	56	21	mg	mg	NOUN
gra-1922	56	22	per	per	ADP
gra-1922	56	23	cycle	cycle	NOUN
gra-1922	56	24	,	,	PUNCT
gra-1922	56	25	whereas	whereas	SCONJ
gra-1922	56	26	patients	patient	NOUN
gra-1922	56	27	in	in	ADP
gra-1922	56	28	group	group	NOUN
gra-1922	56	29	2	2	NUM
gra-1922	56	30	received	receive	VERB
gra-1922	56	31	mean	mean	NOUN
gra-1922	56	32	dose	dose	NOUN
gra-1922	56	33	of	of	ADP
gra-1922	56	34	110.5	110.5	NUM
gra-1922	56	35	mg	mg	NOUN
gra-1922	56	36	per	per	ADP
gra-1922	56	37	cycle	cycle	NOUN
gra-1922	56	38	and	and	CCONJ
gra-1922	56	39	the	the	DET
gra-1922	56	40	observed	observe	VERB
gra-1922	56	41	difference	difference	NOUN
gra-1922	56	42	was	be	AUX
gra-1922	56	43	statistically	statistically	ADV
gra-1922	56	44	highly	highly	ADV
gra-1922	56	45	signicant	signicant	ADJ
gra-1922	56	46	(	(	PUNCT
gra-1922	56	47	p<0.01	p<0.01	PROPN
gra-1922	56	48	)	)	PUNCT
gra-1922	56	49	.	.	PUNCT
gra-1922	57	1	however	however	ADV
gra-1922	57	2	,	,	PUNCT
gra-1922	57	3	total	total	ADJ
gra-1922	57	4	cumulative	cumulative	ADJ
gra-1922	57	5	dose	dose	NOUN
gra-1922	57	6	in	in	ADP
gra-1922	57	7	both	both	CCONJ
gra-1922	57	8	the	the	DET
gra-1922	57	9	groups	group	NOUN
gra-1922	57	10	was	be	AUX
gra-1922	57	11	statistically	statistically	ADV
gra-1922	57	12	similar	similar	ADJ
gra-1922	57	13	with	with	ADP
gra-1922	57	14	a	a	DET
gra-1922	57	15	mean	mean	NOUN
gra-1922	57	16	of	of	ADP
gra-1922	57	17	220	220	NUM
gra-1922	57	18	mg	mg	NOUN
gra-1922	57	19	in	in	ADP
gra-1922	57	20	group	group	NOUN
gra-1922	57	21	1	1	NUM
gra-1922	57	22	as	as	SCONJ
gra-1922	57	23	compared	compare	VERB
gra-1922	57	24	to	to	ADP
gra-1922	57	25	198	198	NUM
gra-1922	57	26	mg	mg	NOUN
gra-1922	57	27	in	in	ADP
gra-1922	57	28	group	group	NOUN
gra-1922	57	29	2	2	NUM
gra-1922	57	30	(	(	PUNCT
gra-1922	57	31	p=0.94	p=0.94	NOUN
gra-1922	57	32	)	)	PUNCT
gra-1922	57	33	.	.	PUNCT
gra-1922	58	1	compliance	compliance	NOUN
gra-1922	58	2	of	of	ADP
gra-1922	58	3	the	the	DET
gra-1922	58	4	treatment	treatment	NOUN
gra-1922	58	5	can	can	AUX
gra-1922	58	6	be	be	AUX
gra-1922	58	7	dened	dene	VERB
gra-1922	58	8	in	in	ADP
gra-1922	58	9	terms	term	NOUN
gra-1922	58	10	of	of	ADP
gra-1922	58	11	completeness	completeness	NOUN
gra-1922	58	12	of	of	ADP
gra-1922	58	13	chemotherapy	chemotherapy	NOUN
gra-1922	58	14	and	and	CCONJ
gra-1922	58	15	radiotherapy	radiotherapy	NOUN
gra-1922	58	16	within	within	ADP
gra-1922	58	17	the	the	DET
gra-1922	58	18	prescribed	prescribed	ADJ
gra-1922	58	19	time	time	NOUN
gra-1922	58	20	limits	limit	NOUN
gra-1922	58	21	.	.	PUNCT
gra-1922	59	1	for	for	ADP
gra-1922	59	2	radiotherapy	radiotherapy	NOUN
gra-1922	59	3	56	56	NUM
gra-1922	59	4	days	day	NOUN
gra-1922	59	5	(	(	PUNCT
gra-1922	59	6	8	8	NUM
gra-1922	59	7	weeks	week	NOUN
gra-1922	59	8	)	)	PUNCT
gra-1922	59	9	was	be	AUX
gra-1922	59	10	taken	take	VERB
gra-1922	59	11	as	as	ADP
gra-1922	59	12	standard	standard	NOUN
gra-1922	59	13	and	and	CCONJ
gra-1922	59	14	chemotherapy	chemotherapy	NOUN
gra-1922	59	15	as	as	ADP
gra-1922	59	16	per	per	ADP
gra-1922	59	17	the	the	DET
gra-1922	59	18	schedule	schedule	NOUN
gra-1922	59	19	.	.	PUNCT
gra-1922	60	1	in	in	ADP
gra-1922	60	2	the	the	DET
gra-1922	60	3	group	group	NOUN
gra-1922	60	4	1	1	NUM
gra-1922	60	5	the	the	DET
gra-1922	60	6	average	average	ADJ
gra-1922	60	7	time	time	NOUN
gra-1922	60	8	of	of	ADP
gra-1922	60	9	completion	completion	NOUN
gra-1922	60	10	of	of	ADP
gra-1922	60	11	radiotherapy	radiotherapy	NOUN
gra-1922	60	12	was	be	AUX
gra-1922	60	13	60	60	NUM
gra-1922	60	14	days	day	NOUN
gra-1922	60	15	,	,	PUNCT
gra-1922	60	16	with	with	ADP
gra-1922	60	17	maximum	maximum	NOUN
gra-1922	60	18	of	of	ADP
gra-1922	60	19	80	80	NUM
gra-1922	60	20	days	day	NOUN
gra-1922	60	21	and	and	CCONJ
gra-1922	60	22	minimum	minimum	NOUN
gra-1922	60	23	of	of	ADP
gra-1922	60	24	50	50	NUM
gra-1922	60	25	days	day	NOUN
gra-1922	60	26	;	;	PUNCT
gra-1922	60	27	15	15	NUM
gra-1922	60	28	patients	patient	NOUN
gra-1922	60	29	(	(	PUNCT
gra-1922	60	30	37.5	37.5	NUM
gra-1922	60	31	%	%	NOUN
gra-1922	60	32	)	)	PUNCT
gra-1922	60	33	completed	complete	VERB
gra-1922	60	34	their	their	PRON
gra-1922	60	35	radiotherapy	radiotherapy	NOUN
gra-1922	60	36	within	within	ADP
gra-1922	60	37	56	56	NUM
gra-1922	60	38	days	day	NOUN
gra-1922	60	39	(	(	PUNCT
gra-1922	60	40	8	8	NUM
gra-1922	60	41	weeks	week	NOUN
gra-1922	60	42	)	)	PUNCT
gra-1922	60	43	of	of	ADP
gra-1922	60	44	starting	start	VERB
gra-1922	60	45	treatment	treatment	NOUN
gra-1922	60	46	,	,	PUNCT
gra-1922	60	47	whereas	whereas	SCONJ
gra-1922	60	48	8	8	NUM
gra-1922	60	49	(	(	PUNCT
gra-1922	60	50	20	20	NUM
gra-1922	60	51	%	%	NOUN
gra-1922	60	52	)	)	PUNCT
gra-1922	60	53	completed	complete	VERB
gra-1922	60	54	within	within	ADP
gra-1922	60	55	63	63	NUM
gra-1922	60	56	days	day	NOUN
gra-1922	60	57	(	(	PUNCT
gra-1922	60	58	9	9	NUM
gra-1922	60	59	weeks	week	NOUN
gra-1922	60	60	)	)	PUNCT
gra-1922	60	61	and	and	CCONJ
gra-1922	60	62	17	17	NUM
gra-1922	60	63	(	(	PUNCT
gra-1922	60	64	42.5	42.5	NUM
gra-1922	60	65	%	%	NOUN
gra-1922	60	66	)	)	PUNCT
gra-1922	60	67	took	take	VERB
gra-1922	60	68	more	more	ADJ
gra-1922	60	69	than	than	ADP
gra-1922	60	70	63	63	NUM
gra-1922	60	71	days	day	NOUN
gra-1922	60	72	(	(	PUNCT
gra-1922	60	73	9	9	NUM
gra-1922	60	74	weeks	week	NOUN
gra-1922	60	75	)	)	PUNCT
gra-1922	60	76	to	to	PART
gra-1922	60	77	complete	complete	VERB
gra-1922	60	78	the	the	DET
gra-1922	60	79	same	same	ADJ
gra-1922	60	80	.	.	PUNCT
gra-1922	61	1	in	in	ADP
gra-1922	61	2	the	the	DET
gra-1922	61	3	group	group	NOUN
gra-1922	61	4	2	2	NUM
gra-1922	61	5	,	,	PUNCT
gra-1922	61	6	in	in	ADP
gra-1922	61	7	which	which	PRON
gra-1922	61	8	the	the	DET
gra-1922	61	9	average	average	ADJ
gra-1922	61	10	treatment	treatment	NOUN
gra-1922	61	11	time	time	NOUN
gra-1922	61	12	was	be	AUX
gra-1922	61	13	61	61	NUM
gra-1922	61	14	days	day	NOUN
gra-1922	61	15	,	,	PUNCT
gra-1922	61	16	maximum	maximum	ADJ
gra-1922	61	17	time	time	NOUN
gra-1922	61	18	being	be	AUX
gra-1922	61	19	83	83	NUM
gra-1922	61	20	days	day	NOUN
gra-1922	61	21	and	and	CCONJ
gra-1922	61	22	minimum	minimum	ADJ
gra-1922	61	23	45	45	NUM
gra-1922	61	24	days	day	NOUN
gra-1922	61	25	;	;	PUNCT
gra-1922	61	26	12	12	NUM
gra-1922	61	27	patients	patient	NOUN
gra-1922	61	28	(	(	PUNCT
gra-1922	61	29	30	30	NUM
gra-1922	61	30	%	%	NOUN
gra-1922	61	31	)	)	PUNCT
gra-1922	61	32	completed	complete	VERB
gra-1922	61	33	within	within	ADP
gra-1922	61	34	the	the	DET
gra-1922	61	35	prescribed	prescribed	ADJ
gra-1922	61	36	time	time	NOUN
gra-1922	61	37	of	of	ADP
gra-1922	61	38	56	56	NUM
gra-1922	61	39	days	day	NOUN
gra-1922	61	40	(	(	PUNCT
gra-1922	61	41	8	8	NUM
gra-1922	61	42	weeks	week	NOUN
gra-1922	61	43	)	)	PUNCT
gra-1922	61	44	,	,	PUNCT
gra-1922	61	45	15	15	NUM
gra-1922	61	46	(	(	PUNCT
gra-1922	61	47	37.5	37.5	NUM
gra-1922	61	48	%	%	NOUN
gra-1922	61	49	)	)	PUNCT
gra-1922	61	50	within	within	ADP
gra-1922	61	51	9	9	NUM
gra-1922	61	52	week	week	NOUN
gra-1922	61	53	and	and	CCONJ
gra-1922	61	54	13	13	NUM
gra-1922	61	55	patients	patient	NOUN
gra-1922	61	56	(	(	PUNCT
gra-1922	61	57	32.5	32.5	NUM
gra-1922	61	58	%	%	NOUN
gra-1922	61	59	)	)	PUNCT
gra-1922	61	60	took	take	VERB
gra-1922	61	61	more	more	ADJ
gra-1922	61	62	than	than	ADP
gra-1922	61	63	63	63	NUM
gra-1922	61	64	day	day	NOUN
gra-1922	61	65	(	(	PUNCT
gra-1922	61	66	9	9	NUM
gra-1922	61	67	weeks	week	NOUN
gra-1922	61	68	)	)	PUNCT
gra-1922	61	69	to	to	PART
gra-1922	61	70	complete	complete	VERB
gra-1922	61	71	the	the	DET
gra-1922	61	72	same	same	ADJ
gra-1922	61	73	.	.	PUNCT
gra-1922	62	1	about	about	ADP
gra-1922	62	2	34	34	NUM
gra-1922	62	3	patients	patient	NOUN
gra-1922	62	4	(	(	PUNCT
gra-1922	62	5	85	85	NUM
gra-1922	62	6	%	%	NOUN
gra-1922	62	7	)	)	PUNCT
gra-1922	62	8	and	and	CCONJ
gra-1922	62	9	37	37	NUM
gra-1922	62	10	(	(	PUNCT
gra-1922	62	11	92.5	92.5	NUM
gra-1922	62	12	%	%	NOUN
gra-1922	62	13	)	)	PUNCT
gra-1922	62	14	in	in	ADP
gra-1922	62	15	group	group	NOUN
gra-1922	62	16	1	1	NUM
gra-1922	62	17	and	and	CCONJ
gra-1922	62	18	group	group	NOUN
gra-1922	62	19	2	2	NUM
gra-1922	62	20	respectively	respectively	ADV
gra-1922	62	21	completed	complete	VERB
gra-1922	62	22	the	the	DET
gra-1922	62	23	full	full	ADJ
gra-1922	62	24	course	course	NOUN
gra-1922	62	25	of	of	ADP
gra-1922	62	26	chemotherapy	chemotherapy	NOUN
gra-1922	62	27	i.e.	i.e.	X
gra-1922	62	28	5	5	NUM
gra-1922	62	29	cycles	cycle	NOUN
gra-1922	62	30	.	.	PUNCT
gra-1922	63	1	4	4	NUM
gra-1922	63	2	cycles	cycle	NOUN
gra-1922	63	3	were	be	AUX
gra-1922	63	4	taken	take	VERB
gra-1922	63	5	by	by	ADP
gra-1922	63	6	4	4	NUM
gra-1922	63	7	(	(	PUNCT
gra-1922	63	8	10	10	NUM
gra-1922	63	9	%	%	NOUN
gra-1922	63	10	)	)	PUNCT
gra-1922	63	11	cases	case	NOUN
gra-1922	63	12	in	in	ADP
gra-1922	63	13	group	group	NOUN
gra-1922	63	14	1	1	NUM
gra-1922	63	15	and	and	CCONJ
gra-1922	63	16	2	2	NUM
gra-1922	63	17	(	(	PUNCT
gra-1922	63	18	5	5	NUM
gra-1922	63	19	%	%	NOUN
gra-1922	63	20	)	)	PUNCT
gra-1922	63	21	patient	patient	NOUN
gra-1922	63	22	in	in	ADP
gra-1922	63	23	group	group	NOUN
gra-1922	63	24	2	2	NUM
gra-1922	63	25	.	.	PUNCT
gra-1922	64	1	however	however	ADV
gra-1922	64	2	,	,	PUNCT
gra-1922	64	3	2	2	NUM
gra-1922	64	4	(	(	PUNCT
gra-1922	64	5	5	5	NUM
gra-1922	64	6	%	%	NOUN
gra-1922	64	7	)	)	PUNCT
gra-1922	64	8	and	and	CCONJ
gra-1922	64	9	1	1	NUM
gra-1922	64	10	(	(	PUNCT
gra-1922	64	11	2.5	2.5	NUM
gra-1922	64	12	%	%	NOUN
gra-1922	64	13	)	)	PUNCT
gra-1922	64	14	patient	patient	NOUN
gra-1922	64	15	respectively	respectively	ADV
gra-1922	64	16	completed	complete	VERB
gra-1922	64	17	only3cycles	only3cycle	NOUN
gra-1922	64	18	of	of	ADP
gra-1922	64	19	chemotherapy	chemotherapy	NOUN
gra-1922	64	20	in	in	ADP
gra-1922	64	21	group	group	NOUN
gra-1922	64	22	1	1	NUM
gra-1922	64	23	and	and	CCONJ
gra-1922	64	24	group	group	NOUN
gra-1922	64	25	2	2	NUM
gra-1922	64	26	.	.	PUNCT
gra-1922	64	27	table	table	NOUN
gra-1922	64	28	3	3	NUM
gra-1922	64	29	:	:	PUNCT
gra-1922	64	30	acute	acute	ADJ
gra-1922	64	31	toxicities	toxicity	NOUN
gra-1922	64	32	in	in	ADP
gra-1922	64	33	participants	participant	NOUN
gra-1922	64	34	of	of	ADP
gra-1922	64	35	2	2	NUM
gra-1922	64	36	groups	group	NOUN
gra-1922	64	37	in	in	ADP
gra-1922	64	38	present	present	ADJ
gra-1922	64	39	study	study	NOUN
gra-1922	64	40	,	,	PUNCT
gra-1922	64	41	all	all	DET
gra-1922	64	42	patients	patient	NOUN
gra-1922	64	43	were	be	AUX
gra-1922	64	44	evaluated	evaluate	VERB
gra-1922	64	45	for	for	ADP
gra-1922	64	46	toxicities	toxicity	NOUN
gra-1922	64	47	based	base	VERB
gra-1922	64	48	upon	upon	SCONJ
gra-1922	64	49	the	the	DET
gra-1922	64	50	guidelines	guideline	NOUN
gra-1922	64	51	of	of	ADP
gra-1922	64	52	national	national	ADJ
gra-1922	64	53	cancer	cancer	PROPN
gra-1922	64	54	institute	institute	PROPN
gra-1922	64	55	common	common	ADJ
gra-1922	64	56	terminology	terminology	NOUN
gra-1922	64	57	criteria	criterion	NOUN
gra-1922	64	58	for	for	ADP
gra-1922	64	59	adverse	adverse	ADJ
gra-1922	64	60	events	event	NOUN
gra-1922	64	61	(	(	PUNCT
gra-1922	64	62	nci	nci	NOUN
gra-1922	65	1	[	[	X
gra-1922	65	2	13]ctcae	13]ctcae	NUM
gra-1922	65	3	)	)	PUNCT
gra-1922	65	4	version	version	NOUN
gra-1922	65	5	4.0	4.0	NUM
gra-1922	65	6	.	.	PUNCT
gra-1922	66	1	no	no	DET
gra-1922	66	2	treatment	treatment	NOUN
gra-1922	66	3	related	relate	VERB
gra-1922	66	4	deaths	death	NOUN
gra-1922	66	5	were	be	AUX
gra-1922	66	6	observed	observe	VERB
gra-1922	66	7	in	in	ADP
gra-1922	66	8	present	present	ADJ
gra-1922	66	9	study	study	NOUN
gra-1922	66	10	.	.	PUNCT
gra-1922	67	1	no	no	DET
gra-1922	67	2	statistically	statistically	ADV
gra-1922	67	3	signicant	signicant	ADJ
gra-1922	67	4	difference	difference	NOUN
gra-1922	67	5	in	in	ADP
gra-1922	67	6	occurrence	occurrence	NOUN
gra-1922	67	7	of	of	ADP
gra-1922	67	8	acute	acute	ADJ
gra-1922	67	9	toxicities	toxicity	NOUN
gra-1922	67	10	between	between	ADP
gra-1922	67	11	the	the	DET
gra-1922	67	12	participants	participant	NOUN
gra-1922	67	13	of	of	ADP
gra-1922	67	14	two	two	NUM
gra-1922	67	15	groups	group	NOUN
gra-1922	67	16	was	be	AUX
gra-1922	67	17	observed	observe	VERB
gra-1922	67	18	(	(	PUNCT
gra-1922	67	19	p>0.05	p>0.05	NOUN
gra-1922	67	20	)	)	PUNCT
gra-1922	67	21	.	.	PUNCT
gra-1922	68	1	table	table	NOUN
gra-1922	68	2	4distribution	4distribution	NUM
gra-1922	68	3	according	accord	VERB
gra-1922	68	4	to	to	ADP
gra-1922	68	5	response	response	NOUN
gra-1922	68	6	to	to	ADP
gra-1922	68	7	treatment	treatment	NOUN
gra-1922	68	8	in	in	ADP
gra-1922	68	9	both	both	CCONJ
gra-1922	68	10	the	the	DET
gra-1922	68	11	groups	group	NOUN
gra-1922	68	12	the	the	DET
gra-1922	68	13	patients	patient	NOUN
gra-1922	68	14	were	be	AUX
gra-1922	68	15	followed	follow	VERB
gra-1922	68	16	up	up	ADP
gra-1922	68	17	at	at	ADP
gra-1922	68	18	specied	specied	PROPN
gra-1922	68	19	interval	interval	NOUN
gra-1922	68	20	and	and	CCONJ
gra-1922	68	21	nal	nal	ADJ
gra-1922	68	22	response	response	NOUN
gra-1922	68	23	was	be	AUX
gra-1922	68	24	observed	observe	VERB
gra-1922	68	25	at	at	ADP
gra-1922	68	26	6	6	NUM
gra-1922	68	27	weeks	week	NOUN
gra-1922	68	28	after	after	ADP
gra-1922	68	29	completion	completion	NOUN
gra-1922	68	30	of	of	ADP
gra-1922	68	31	therapy	therapy	NOUN
gra-1922	68	32	.	.	PUNCT
gra-1922	69	1	clinically	clinically	ADV
gra-1922	69	2	,	,	PUNCT
gra-1922	69	3	complete	complete	ADJ
gra-1922	69	4	response	response	NOUN
gra-1922	69	5	was	be	AUX
gra-1922	69	6	noted	note	VERB
gra-1922	69	7	in	in	ADP
gra-1922	69	8	82.5	82.5	NUM
gra-1922	69	9	%	%	NOUN
gra-1922	69	10	and	and	CCONJ
gra-1922	69	11	90	90	NUM
gra-1922	69	12	%	%	NOUN
gra-1922	69	13	patients	patient	NOUN
gra-1922	69	14	in	in	ADP
gra-1922	69	15	group	group	NOUN
gra-1922	69	16	1	1	NUM
gra-1922	69	17	and	and	CCONJ
gra-1922	69	18	group	group	NOUN
gra-1922	69	19	2	2	NUM
gra-1922	69	20	respectively	respectively	ADV
gra-1922	69	21	.	.	PUNCT
gra-1922	70	1	however	however	ADV
gra-1922	70	2	the	the	DET
gra-1922	70	3	observed	observed	ADJ
gra-1922	70	4	difference	difference	NOUN
gra-1922	70	5	in	in	ADP
gra-1922	70	6	response	response	NOUN
gra-1922	70	7	was	be	AUX
gra-1922	70	8	not	not	PART
gra-1922	70	9	statistically	statistically	ADV
gra-1922	70	10	signicant	signicant	ADJ
gra-1922	70	11	(	(	PUNCT
gra-1922	70	12	p>0.05	p>0.05	PROPN
gra-1922	70	13	)	)	PUNCT
gra-1922	70	14	.	.	PUNCT
gra-1922	71	1	volume-9	volume-9	NUM
gra-1922	71	2	,	,	PUNCT
gra-1922	71	3	issue-2	issue-2	PROPN
gra-1922	71	4	,	,	PUNCT
gra-1922	71	5	february-2020	february-2020	VERB
gra-1922	71	6	•	•	NUM
gra-1922	71	7	print	print	NOUN
gra-1922	71	8	issn	issn	PROPN
gra-1922	71	9	no	no	NOUN
gra-1922	71	10	.	.	PROPN
gra-1922	72	1	2277	2277	NUM
gra-1922	72	2	8160	8160	NUM
gra-1922	72	3	•	•	NOUN
gra-1922	72	4	doi	doi	NOUN
gra-1922	72	5	:	:	PUNCT
gra-1922	72	6	10.36106	10.36106	NUM
gra-1922	72	7	/	/	SYM
gra-1922	72	8	gjra	gjra	NOUN
gra-1922	72	9	sociodemographic	sociodemographic	PROPN
gra-1922	72	10	variables	variable	NOUN
gra-1922	72	11	group	group	NOUN
gra-1922	72	12	1	1	NUM
gra-1922	72	13	(	(	PUNCT
gra-1922	72	14	%	%	NOUN
gra-1922	72	15	)	)	PUNCT
gra-1922	72	16	group	group	NOUN
gra-1922	72	17	2	2	NUM
gra-1922	72	18	(	(	PUNCT
gra-1922	72	19	%	%	NOUN
gra-1922	72	20	)	)	PUNCT
gra-1922	72	21	p	p	NOUN
gra-1922	72	22	value	value	NOUN
gra-1922	72	23	age	age	NOUN
gra-1922	72	24	group	group	NOUN
gra-1922	72	25	(	(	PUNCT
gra-1922	72	26	years	year	NOUN
gra-1922	72	27	)	)	PUNCT
gra-1922	72	28	<	<	X
gra-1922	72	29	40	40	NUM
gra-1922	72	30	9	9	NUM
gra-1922	72	31	(	(	PUNCT
gra-1922	72	32	22.5	22.5	NUM
gra-1922	72	33	)	)	PUNCT
gra-1922	72	34	6	6	NUM
gra-1922	72	35	(	(	PUNCT
gra-1922	72	36	15	15	NUM
gra-1922	72	37	)	)	PUNCT
gra-1922	72	38	0.78	0.78	NUM
gra-1922	72	39	40	40	NUM
gra-1922	72	40	-	-	SYM
gra-1922	72	41	49	49	NUM
gra-1922	72	42	16	16	NUM
gra-1922	72	43	(	(	PUNCT
gra-1922	72	44	40	40	NUM
gra-1922	72	45	)	)	PUNCT
gra-1922	72	46	20	20	NUM
gra-1922	72	47	(	(	PUNCT
gra-1922	72	48	50	50	NUM
gra-1922	72	49	)	)	PUNCT
gra-1922	72	50	50	50	NUM
gra-1922	72	51	-	-	SYM
gra-1922	72	52	59	59	NUM
gra-1922	72	53	11	11	NUM
gra-1922	72	54	(	(	PUNCT
gra-1922	72	55	27.5	27.5	NUM
gra-1922	72	56	)	)	SYM
gra-1922	72	57	10	10	NUM
gra-1922	72	58	(	(	PUNCT
gra-1922	72	59	25	25	NUM
gra-1922	72	60	)	)	PUNCT
gra-1922	72	61	60	60	NUM
gra-1922	72	62	-	-	SYM
gra-1922	72	63	69	69	NUM
gra-1922	72	64	4	4	NUM
gra-1922	72	65	(	(	PUNCT
gra-1922	72	66	10	10	NUM
gra-1922	72	67	)	)	SYM
gra-1922	72	68	4	4	NUM
gra-1922	72	69	(	(	PUNCT
gra-1922	72	70	10	10	NUM
gra-1922	72	71	)	)	PUNCT
gra-1922	72	72	residence	residence	NOUN
gra-1922	72	73	rural	rural	ADJ
gra-1922	72	74	25(62.5	25(62.5	NOUN
gra-1922	72	75	)	)	PUNCT
gra-1922	72	76	30	30	NUM
gra-1922	72	77	(	(	PUNCT
gra-1922	72	78	75	75	NUM
gra-1922	72	79	)	)	PUNCT
gra-1922	72	80	0.22	0.22	NUM
gra-1922	72	81	urban	urban	ADJ
gra-1922	72	82	15(37.5	15(37.5	NOUN
gra-1922	72	83	)	)	PUNCT
gra-1922	72	84	10	10	NUM
gra-1922	72	85	(	(	PUNCT
gra-1922	72	86	25	25	NUM
gra-1922	72	87	)	)	PUNCT
gra-1922	72	88	ecog	ecog	VERB
gra-1922	72	89	status	status	NOUN
gra-1922	72	90	0	0	NUM
gra-1922	72	91	0	0	NUM
gra-1922	72	92	(	(	PUNCT
gra-1922	72	93	0	0	NUM
gra-1922	72	94	)	)	PUNCT
gra-1922	72	95	0	0	NUM
gra-1922	73	1	(	(	PUNCT
gra-1922	73	2	0	0	NUM
gra-1922	73	3	)	)	PUNCT
gra-1922	73	4	0.61	0.61	NUM
gra-1922	73	5	1	1	NUM
gra-1922	73	6	29	29	NUM
gra-1922	73	7	(	(	PUNCT
gra-1922	73	8	72.5	72.5	NUM
gra-1922	73	9	)	)	PUNCT
gra-1922	73	10	31	31	NUM
gra-1922	73	11	(	(	PUNCT
gra-1922	73	12	77	77	NUM
gra-1922	73	13	)	)	PUNCT
gra-1922	73	14	2	2	NUM
gra-1922	73	15	11(27.5	11(27.5	NUM
gra-1922	73	16	)	)	PUNCT
gra-1922	73	17	9	9	NUM
gra-1922	73	18	(	(	PUNCT
gra-1922	73	19	22.5	22.5	NUM
gra-1922	73	20	)	)	PUNCT
gra-1922	73	21	socioeconomi	socioeconomi	NOUN
gra-1922	73	22	c	c	PROPN
gra-1922	73	23	status	status	NOUN
gra-1922	73	24	low	low	ADJ
gra-1922	73	25	22(55	22(55	NOUN
gra-1922	73	26	)	)	PUNCT
gra-1922	73	27	24	24	NUM
gra-1922	73	28	(	(	PUNCT
gra-1922	73	29	60	60	NUM
gra-1922	73	30	)	)	PUNCT
gra-1922	73	31	0.65	0.65	NUM
gra-1922	73	32	middle	middle	NOUN
gra-1922	73	33	17	17	NUM
gra-1922	73	34	(	(	PUNCT
gra-1922	73	35	42.5	42.5	NUM
gra-1922	73	36	)	)	PUNCT
gra-1922	73	37	16	16	NUM
gra-1922	73	38	(	(	PUNCT
gra-1922	73	39	40	40	NUM
gra-1922	73	40	)	)	PUNCT
gra-1922	73	41	high	high	ADJ
gra-1922	73	42	1(2.5	1(2.5	NUM
gra-1922	73	43	)	)	PUNCT
gra-1922	73	44	0	0	NUM
gra-1922	73	45	stage	stage	NOUN
gra-1922	73	46	iib	iib	NOUN
gra-1922	73	47	22	22	NUM
gra-1922	73	48	(	(	PUNCT
gra-1922	73	49	55	55	NUM
gra-1922	73	50	)	)	PUNCT
gra-1922	73	51	30	30	NUM
gra-1922	73	52	(	(	PUNCT
gra-1922	73	53	75	75	NUM
gra-1922	73	54	)	)	PUNCT
gra-1922	73	55	0.06	0.06	NUM
gra-1922	73	56	iiib	iiib	NOUN
gra-1922	73	57	18	18	NUM
gra-1922	73	58	(	(	PUNCT
gra-1922	73	59	46	46	NUM
gra-1922	73	60	)	)	PUNCT
gra-1922	73	61	10	10	NUM
gra-1922	73	62	(	(	PUNCT
gra-1922	73	63	25	25	NUM
gra-1922	73	64	)	)	PUNCT
gra-1922	73	65	chemotherapy	chemotherapy	NOUN
gra-1922	73	66	group	group	NOUN
gra-1922	73	67	1	1	NUM
gra-1922	73	68	(	(	PUNCT
gra-1922	73	69	%	%	NOUN
gra-1922	73	70	)	)	PUNCT
gra-1922	73	71	group	group	NOUN
gra-1922	73	72	2	2	NUM
gra-1922	73	73	(	(	PUNCT
gra-1922	73	74	%	%	NOUN
gra-1922	73	75	)	)	PUNCT
gra-1922	73	76	p	p	NOUN
gra-1922	73	77	value	value	NOUN
gra-1922	73	78	dose	dose	VERB
gra-1922	73	79	per	per	ADP
gra-1922	73	80	cycle	cycle	NOUN
gra-1922	73	81	(	(	PUNCT
gra-1922	73	82	mg	mg	PROPN
gra-1922	73	83	)	)	PUNCT
gra-1922	73	84	45.5	45.5	NUM
gra-1922	73	85	110.5	110.5	NUM
gra-1922	73	86	0.003	0.003	NUM
gra-1922	73	87	cumulative	cumulative	ADJ
gra-1922	73	88	dose	dose	NOUN
gra-1922	73	89	(	(	PUNCT
gra-1922	73	90	mg	mg	PROPN
gra-1922	73	91	)	)	PUNCT
gra-1922	73	92	220	220	NUM
gra-1922	73	93	198	198	NUM
gra-1922	73	94	0.94	0.94	NUM
gra-1922	73	95	acute	acute	ADJ
gra-1922	73	96	toxicities	toxicity	NOUN
gra-1922	73	97	group	group	NOUN
gra-1922	73	98	grade	grade	NOUN
gra-1922	73	99	1	1	NUM
gra-1922	73	100	grade	grade	NOUN
gra-1922	73	101	2	2	NUM
gra-1922	73	102	grade	grade	NOUN
gra-1922	73	103	3grade	3grade	NUM
gra-1922	73	104	4	4	NUM
gra-1922	73	105	p	p	NOUN
gra-1922	73	106	value	value	NOUN
gra-1922	73	107	nausea	nausea	NOUN
gra-1922	73	108	1	1	NUM
gra-1922	73	109	28	28	NUM
gra-1922	73	110	(	(	PUNCT
gra-1922	73	111	70	70	NUM
gra-1922	73	112	)	)	PUNCT
gra-1922	73	113	12	12	NUM
gra-1922	73	114	(	(	PUNCT
gra-1922	73	115	30	30	NUM
gra-1922	73	116	)	)	PUNCT
gra-1922	73	117	0	0	NUM
gra-1922	74	1	(	(	PUNCT
gra-1922	74	2	0	0	NUM
gra-1922	74	3	)	)	PUNCT
gra-1922	74	4	0	0	NUM
gra-1922	75	1	(	(	PUNCT
gra-1922	75	2	0	0	NUM
gra-1922	75	3	)	)	PUNCT
gra-1922	76	1	0.24	0.24	NUM
gra-1922	76	2	2	2	NUM
gra-1922	76	3	23	23	NUM
gra-1922	76	4	(	(	PUNCT
gra-1922	76	5	57.5	57.5	NUM
gra-1922	76	6	)	)	PUNCT
gra-1922	76	7	14	14	NUM
gra-1922	76	8	(	(	PUNCT
gra-1922	76	9	35	35	NUM
gra-1922	76	10	)	)	PUNCT
gra-1922	76	11	3	3	NUM
gra-1922	76	12	(	(	PUNCT
gra-1922	76	13	7.5	7.5	NUM
gra-1922	76	14	)	)	PUNCT
gra-1922	76	15	0	0	NUM
gra-1922	77	1	(	(	PUNCT
gra-1922	77	2	0	0	NUM
gra-1922	77	3	)	)	PUNCT
gra-1922	77	4	vomiting	vomit	VERB
gra-1922	77	5	1	1	NUM
gra-1922	77	6	19	19	NUM
gra-1922	77	7	(	(	PUNCT
gra-1922	77	8	47.5	47.5	NUM
gra-1922	77	9	)	)	PUNCT
gra-1922	77	10	13	13	NUM
gra-1922	77	11	(	(	PUNCT
gra-1922	77	12	32.5	32.5	NUM
gra-1922	77	13	)	)	PUNCT
gra-1922	77	14	0	0	NUM
gra-1922	78	1	(	(	PUNCT
gra-1922	78	2	0	0	NUM
gra-1922	78	3	)	)	PUNCT
gra-1922	78	4	0	0	NUM
gra-1922	79	1	(	(	PUNCT
gra-1922	79	2	0	0	NUM
gra-1922	79	3	)	)	PUNCT
gra-1922	80	1	0.07	0.07	NUM
gra-1922	80	2	2	2	NUM
gra-1922	80	3	13	13	NUM
gra-1922	80	4	(	(	PUNCT
gra-1922	80	5	32.5	32.5	NUM
gra-1922	80	6	)	)	PUNCT
gra-1922	80	7	22	22	NUM
gra-1922	80	8	(	(	PUNCT
gra-1922	80	9	55	55	NUM
gra-1922	80	10	)	)	PUNCT
gra-1922	80	11	0	0	NUM
gra-1922	80	12	(	(	PUNCT
gra-1922	80	13	0	0	NUM
gra-1922	80	14	)	)	PUNCT
gra-1922	80	15	0	0	NUM
gra-1922	81	1	(	(	PUNCT
gra-1922	81	2	0	0	X
gra-1922	81	3	)	)	PUNCT
gra-1922	81	4	diarrhea	diarrhea	NOUN
gra-1922	81	5	1	1	NUM
gra-1922	81	6	22	22	NUM
gra-1922	81	7	(	(	PUNCT
gra-1922	81	8	55	55	NUM
gra-1922	81	9	)	)	PUNCT
gra-1922	81	10	7	7	NUM
gra-1922	81	11	(	(	PUNCT
gra-1922	81	12	17.5	17.5	NUM
gra-1922	81	13	)	)	SYM
gra-1922	81	14	2	2	NUM
gra-1922	81	15	(	(	PUNCT
gra-1922	81	16	5	5	NUM
gra-1922	81	17	)	)	PUNCT
gra-1922	81	18	0	0	NUM
gra-1922	82	1	(	(	PUNCT
gra-1922	82	2	0	0	NUM
gra-1922	82	3	)	)	PUNCT
gra-1922	82	4	0.2	0.2	NUM
gra-1922	82	5	2	2	NUM
gra-1922	82	6	29	29	NUM
gra-1922	82	7	(	(	PUNCT
gra-1922	82	8	72.5	72.5	NUM
gra-1922	82	9	)	)	PUNCT
gra-1922	82	10	5	5	NUM
gra-1922	82	11	(	(	PUNCT
gra-1922	82	12	12.5	12.5	NUM
gra-1922	82	13	)	)	PUNCT
gra-1922	82	14	0	0	NUM
gra-1922	83	1	(	(	PUNCT
gra-1922	83	2	0	0	NUM
gra-1922	83	3	)	)	PUNCT
gra-1922	83	4	0	0	NUM
gra-1922	84	1	(	(	PUNCT
gra-1922	84	2	0	0	X
gra-1922	84	3	)	)	PUNCT
gra-1922	84	4	nephrot	nephrot	NOUN
gra-1922	84	5	oxicity	oxicity	NOUN
gra-1922	84	6	1	1	NUM
gra-1922	84	7	3	3	NUM
gra-1922	84	8	(	(	PUNCT
gra-1922	84	9	7.5	7.5	NUM
gra-1922	84	10	)	)	PUNCT
gra-1922	84	11	0	0	NUM
gra-1922	85	1	(	(	PUNCT
gra-1922	85	2	0	0	NUM
gra-1922	85	3	)	)	PUNCT
gra-1922	85	4	0	0	NUM
gra-1922	86	1	(	(	PUNCT
gra-1922	86	2	0	0	NUM
gra-1922	86	3	)	)	PUNCT
gra-1922	86	4	0	0	NUM
gra-1922	87	1	(	(	PUNCT
gra-1922	87	2	0	0	NUM
gra-1922	87	3	)	)	PUNCT
gra-1922	87	4	0.06	0.06	NUM
gra-1922	88	1	2	2	NUM
gra-1922	88	2	9	9	NUM
gra-1922	88	3	(	(	PUNCT
gra-1922	88	4	22.5	22.5	NUM
gra-1922	88	5	)	)	PUNCT
gra-1922	88	6	0	0	NUM
gra-1922	88	7	(	(	PUNCT
gra-1922	88	8	0	0	NUM
gra-1922	88	9	)	)	PUNCT
gra-1922	88	10	0	0	NUM
gra-1922	88	11	(	(	PUNCT
gra-1922	88	12	0	0	NUM
gra-1922	88	13	)	)	PUNCT
gra-1922	88	14	0	0	NUM
gra-1922	88	15	(	(	PUNCT
gra-1922	88	16	0	0	NUM
gra-1922	88	17	)	)	PUNCT
gra-1922	88	18	hyponat	hyponat	NOUN
gra-1922	88	19	remia	remia	NOUN
gra-1922	88	20	1	1	NUM
gra-1922	88	21	4	4	NUM
gra-1922	88	22	(	(	PUNCT
gra-1922	88	23	10	10	NUM
gra-1922	88	24	)	)	PUNCT
gra-1922	88	25	0	0	NUM
gra-1922	88	26	(	(	PUNCT
gra-1922	88	27	0	0	NUM
gra-1922	88	28	)	)	PUNCT
gra-1922	88	29	0	0	NUM
gra-1922	88	30	(	(	PUNCT
gra-1922	88	31	0	0	NUM
gra-1922	88	32	)	)	PUNCT
gra-1922	88	33	0	0	NUM
gra-1922	88	34	(	(	PUNCT
gra-1922	88	35	0	0	NUM
gra-1922	88	36	)	)	PUNCT
gra-1922	88	37	0.13	0.13	NUM
gra-1922	88	38	2	2	NUM
gra-1922	88	39	9	9	NUM
gra-1922	88	40	(	(	PUNCT
gra-1922	88	41	22.5	22.5	NUM
gra-1922	88	42	)	)	PUNCT
gra-1922	88	43	0	0	NUM
gra-1922	88	44	(	(	PUNCT
gra-1922	88	45	0	0	NUM
gra-1922	88	46	)	)	PUNCT
gra-1922	88	47	0	0	NUM
gra-1922	88	48	(	(	PUNCT
gra-1922	88	49	0	0	NUM
gra-1922	88	50	)	)	PUNCT
gra-1922	88	51	0	0	NUM
gra-1922	89	1	(	(	PUNCT
gra-1922	89	2	0	0	NUM
gra-1922	89	3	)	)	PUNCT
gra-1922	89	4	hypokal	hypokal	NOUN
gra-1922	89	5	emia	emia	NOUN
gra-1922	89	6	1	1	NUM
gra-1922	89	7	4	4	NUM
gra-1922	89	8	(	(	PUNCT
gra-1922	89	9	10	10	NUM
gra-1922	89	10	)	)	PUNCT
gra-1922	89	11	0	0	NUM
gra-1922	89	12	(	(	PUNCT
gra-1922	89	13	0	0	NUM
gra-1922	89	14	)	)	PUNCT
gra-1922	89	15	0	0	NUM
gra-1922	90	1	(	(	PUNCT
gra-1922	90	2	0	0	NUM
gra-1922	90	3	)	)	PUNCT
gra-1922	90	4	0	0	NUM
gra-1922	91	1	(	(	PUNCT
gra-1922	91	2	0	0	NUM
gra-1922	91	3	)	)	PUNCT
gra-1922	91	4	1.0	1.0	NUM
gra-1922	91	5	2	2	NUM
gra-1922	91	6	2	2	NUM
gra-1922	91	7	(	(	PUNCT
gra-1922	91	8	5	5	NUM
gra-1922	91	9	)	)	SYM
gra-1922	91	10	2	2	NUM
gra-1922	91	11	(	(	PUNCT
gra-1922	91	12	5	5	NUM
gra-1922	91	13	)	)	PUNCT
gra-1922	91	14	0	0	NUM
gra-1922	91	15	(	(	PUNCT
gra-1922	91	16	0	0	NUM
gra-1922	91	17	)	)	PUNCT
gra-1922	91	18	0	0	NUM
gra-1922	92	1	(	(	PUNCT
gra-1922	92	2	0	0	NUM
gra-1922	92	3	)	)	PUNCT
gra-1922	92	4	weight	weight	NOUN
gra-1922	92	5	loss	loss	NOUN
gra-1922	92	6	1	1	NUM
gra-1922	92	7	13	13	NUM
gra-1922	92	8	(	(	PUNCT
gra-1922	92	9	32.5	32.5	NUM
gra-1922	92	10	)	)	PUNCT
gra-1922	92	11	3	3	NUM
gra-1922	92	12	(	(	PUNCT
gra-1922	92	13	7.5	7.5	NUM
gra-1922	92	14	)	)	PUNCT
gra-1922	92	15	0	0	NUM
gra-1922	92	16	(	(	PUNCT
gra-1922	92	17	0	0	NUM
gra-1922	92	18	)	)	PUNCT
gra-1922	92	19	0	0	NUM
gra-1922	93	1	(	(	PUNCT
gra-1922	93	2	0	0	NUM
gra-1922	93	3	)	)	PUNCT
gra-1922	93	4	0.37	0.37	NUM
gra-1922	93	5	2	2	NUM
gra-1922	93	6	15	15	NUM
gra-1922	93	7	(	(	PUNCT
gra-1922	93	8	37.5	37.5	NUM
gra-1922	93	9	)	)	PUNCT
gra-1922	93	10	7	7	NUM
gra-1922	93	11	(	(	PUNCT
gra-1922	93	12	17.5	17.5	NUM
gra-1922	93	13	)	)	PUNCT
gra-1922	93	14	0	0	NUM
gra-1922	94	1	(	(	PUNCT
gra-1922	94	2	0	0	NUM
gra-1922	94	3	)	)	PUNCT
gra-1922	94	4	0	0	NUM
gra-1922	95	1	(	(	PUNCT
gra-1922	95	2	0	0	NUM
gra-1922	95	3	)	)	PUNCT
gra-1922	95	4	anemia	anemia	NOUN
gra-1922	95	5	1	1	NUM
gra-1922	95	6	24	24	NUM
gra-1922	95	7	(	(	PUNCT
gra-1922	95	8	60	60	NUM
gra-1922	95	9	)	)	PUNCT
gra-1922	95	10	6	6	NUM
gra-1922	95	11	(	(	PUNCT
gra-1922	95	12	15	15	NUM
gra-1922	95	13	)	)	SYM
gra-1922	95	14	2	2	NUM
gra-1922	95	15	(	(	PUNCT
gra-1922	95	16	5	5	NUM
gra-1922	95	17	)	)	PUNCT
gra-1922	95	18	0	0	NUM
gra-1922	96	1	(	(	PUNCT
gra-1922	96	2	0	0	NUM
gra-1922	96	3	)	)	PUNCT
gra-1922	96	4	0.61	0.61	NUM
gra-1922	96	5	2	2	NUM
gra-1922	96	6	25	25	NUM
gra-1922	96	7	(	(	PUNCT
gra-1922	96	8	62.5	62.5	NUM
gra-1922	96	9	)	)	PUNCT
gra-1922	96	10	11	11	NUM
gra-1922	96	11	(	(	PUNCT
gra-1922	96	12	27.5	27.5	NUM
gra-1922	96	13	)	)	PUNCT
gra-1922	96	14	0	0	NUM
gra-1922	97	1	(	(	PUNCT
gra-1922	97	2	0	0	NUM
gra-1922	97	3	)	)	PUNCT
gra-1922	97	4	0	0	NUM
gra-1922	98	1	(	(	PUNCT
gra-1922	98	2	0	0	NUM
gra-1922	98	3	)	)	PUNCT
gra-1922	98	4	tlc	tlc	NOUN
gra-1922	98	5	1	1	NUM
gra-1922	98	6	1	1	NUM
gra-1922	98	7	(	(	PUNCT
gra-1922	98	8	2.5	2.5	NUM
gra-1922	98	9	)	)	PUNCT
gra-1922	98	10	11	11	NUM
gra-1922	98	11	(	(	PUNCT
gra-1922	98	12	27.5	27.5	NUM
gra-1922	98	13	)	)	PUNCT
gra-1922	98	14	0	0	NUM
gra-1922	99	1	(	(	PUNCT
gra-1922	99	2	0	0	NUM
gra-1922	99	3	)	)	PUNCT
gra-1922	99	4	0	0	NUM
gra-1922	100	1	(	(	PUNCT
gra-1922	100	2	0	0	NUM
gra-1922	100	3	)	)	PUNCT
gra-1922	101	1	0.07	0.07	NUM
gra-1922	101	2	2	2	NUM
gra-1922	101	3	6	6	NUM
gra-1922	101	4	(	(	PUNCT
gra-1922	101	5	15	15	NUM
gra-1922	101	6	)	)	PUNCT
gra-1922	101	7	9	9	NUM
gra-1922	101	8	(	(	PUNCT
gra-1922	101	9	22.5	22.5	NUM
gra-1922	101	10	)	)	PUNCT
gra-1922	101	11	0	0	NUM
gra-1922	102	1	(	(	PUNCT
gra-1922	102	2	0	0	NUM
gra-1922	102	3	)	)	PUNCT
gra-1922	102	4	0	0	NUM
gra-1922	103	1	(	(	PUNCT
gra-1922	103	2	0	0	NUM
gra-1922	103	3	)	)	PUNCT
gra-1922	103	4	anc	anc	PROPN
gra-1922	103	5	1	1	NUM
gra-1922	103	6	5	5	NUM
gra-1922	103	7	(	(	PUNCT
gra-1922	103	8	12.5	12.5	NUM
gra-1922	103	9	)	)	PUNCT
gra-1922	103	10	3	3	NUM
gra-1922	103	11	(	(	PUNCT
gra-1922	103	12	7.5	7.5	NUM
gra-1922	103	13	)	)	PUNCT
gra-1922	103	14	0	0	NUM
gra-1922	104	1	(	(	PUNCT
gra-1922	104	2	0	0	NUM
gra-1922	104	3	)	)	PUNCT
gra-1922	104	4	0	0	NUM
gra-1922	105	1	(	(	PUNCT
gra-1922	105	2	0	0	NUM
gra-1922	105	3	)	)	PUNCT
gra-1922	105	4	0.36	0.36	NUM
gra-1922	105	5	2	2	NUM
gra-1922	105	6	1	1	NUM
gra-1922	105	7	(	(	PUNCT
gra-1922	105	8	2.5	2.5	NUM
gra-1922	105	9	)	)	PUNCT
gra-1922	105	10	4	4	NUM
gra-1922	105	11	(	(	PUNCT
gra-1922	105	12	10	10	NUM
gra-1922	105	13	)	)	PUNCT
gra-1922	105	14	0	0	NUM
gra-1922	106	1	(	(	PUNCT
gra-1922	106	2	0	0	NUM
gra-1922	106	3	)	)	PUNCT
gra-1922	106	4	0	0	NUM
gra-1922	107	1	(	(	PUNCT
gra-1922	107	2	0	0	NUM
gra-1922	107	3	)	)	PUNCT
gra-1922	107	4	response	response	NOUN
gra-1922	107	5	to	to	ADP
gra-1922	107	6	treatment	treatment	NOUN
gra-1922	107	7	group	group	NOUN
gra-1922	107	8	1	1	NUM
gra-1922	107	9	(	(	PUNCT
gra-1922	107	10	%	%	NOUN
gra-1922	107	11	)	)	PUNCT
gra-1922	107	12	group	group	NOUN
gra-1922	107	13	2	2	NUM
gra-1922	107	14	(	(	PUNCT
gra-1922	107	15	%	%	NOUN
gra-1922	107	16	)	)	PUNCT
gra-1922	107	17	p	p	NOUN
gra-1922	107	18	value	value	NOUN
gra-1922	107	19	complete	complete	ADJ
gra-1922	107	20	response	response	NOUN
gra-1922	107	21	33	33	NUM
gra-1922	107	22	(	(	PUNCT
gra-1922	107	23	82.5	82.5	NUM
gra-1922	107	24	)	)	PUNCT
gra-1922	107	25	36	36	NUM
gra-1922	107	26	(	(	PUNCT
gra-1922	107	27	90	90	NUM
gra-1922	107	28	)	)	PUNCT
gra-1922	107	29	0.33	0.33	NUM
gra-1922	107	30	partial	partial	ADJ
gra-1922	107	31	response	response	NOUN
gra-1922	107	32	7	7	NUM
gra-1922	107	33	(	(	PUNCT
gra-1922	107	34	17.5	17.5	NUM
gra-1922	107	35	)	)	SYM
gra-1922	107	36	4	4	NUM
gra-1922	107	37	(	(	PUNCT
gra-1922	107	38	10	10	NUM
gra-1922	107	39	)	)	PUNCT
gra-1922	107	40	discussion	discussion	NOUN
gra-1922	107	41	concurrent	concurrent	ADJ
gra-1922	107	42	chemoradiation	chemoradiation	NOUN
gra-1922	107	43	with	with	ADP
gra-1922	107	44	the	the	DET
gra-1922	107	45	help	help	NOUN
gra-1922	107	46	of	of	ADP
gra-1922	107	47	cisplatin	cisplatin	NOUN
gra-1922	107	48	is	be	AUX
gra-1922	107	49	a	a	DET
gra-1922	107	50	“	"	PUNCT
gra-1922	107	51	standard	standard	NOUN
gra-1922	107	52	of	of	ADP
gra-1922	107	53	care	care	NOUN
gra-1922	107	54	”	"	PUNCT
gra-1922	107	55	for	for	ADP
gra-1922	107	56	women	woman	NOUN
gra-1922	107	57	with	with	ADP
gra-1922	107	58	locally	locally	ADV
gra-1922	107	59	advanced	advanced	ADJ
gra-1922	107	60	carcinoma	carcinoma	NOUN
gra-1922	107	61	cervix	cervix	NOUN
gra-1922	107	62	.	.	PUNCT
gra-1922	108	1	this	this	PRON
gra-1922	108	2	was	be	AUX
gra-1922	108	3	in	in	ADP
gra-1922	108	4	response	response	NOUN
gra-1922	108	5	to	to	ADP
gra-1922	108	6	a	a	DET
gra-1922	108	7	national	national	PROPN
gra-1922	108	8	cancer	cancer	PROPN
gra-1922	108	9	institute	institute	PROPN
gra-1922	108	10	alert	alert	PROPN
gra-1922	108	11	based	base	VERB
gra-1922	108	12	results	result	NOUN
gra-1922	108	13	of	of	ADP
gra-1922	108	14	ve	ve	PROPN
gra-1922	108	15	randomized	randomize	VERB
gra-1922	108	16	trials	trial	NOUN
gra-1922	108	17	stating	state	VERB
gra-1922	108	18	“	"	PUNCT
gra-1922	108	19	strong	strong	ADJ
gra-1922	108	20	consideration	consideration	NOUN
gra-1922	108	21	should	should	AUX
gra-1922	108	22	be	be	AUX
gra-1922	108	23	given	give	VERB
gra-1922	108	24	to	to	ADP
gra-1922	108	25	the	the	DET
gra-1922	108	26	incorporation	incorporation	NOUN
gra-1922	108	27	of	of	ADP
gra-1922	108	28	chemotherapy	chemotherapy	NOUN
gra-1922	108	29	and	and	CCONJ
gra-1922	108	30	radiotherapy	radiotherapy	NOUN
gra-1922	108	31	for	for	ADP
gra-1922	108	32	the	the	DET
gra-1922	108	33	treatment	treatment	NOUN
gra-1922	108	34	of	of	ADP
gra-1922	108	35	cervical	cervical	ADJ
gra-1922	108	36	[	[	X
gra-1922	108	37	14	14	NUM
gra-1922	108	38	]	]	PUNCT
gra-1922	108	39	cancer	cancer	NOUN
gra-1922	108	40	.	.	PUNCT
gra-1922	109	1	weekly	weekly	ADJ
gra-1922	109	2	cisplatin	cisplatin	NOUN
gra-1922	109	3	based	base	VERB
gra-1922	109	4	treatment	treatment	NOUN
gra-1922	109	5	regimen	regiman	NOUN
gra-1922	109	6	was	be	AUX
gra-1922	109	7	recommended	recommend	VERB
gra-1922	109	8	by	by	ADP
gra-1922	109	9	national	national	ADJ
gra-1922	109	10	comprehensive	comprehensive	ADJ
gra-1922	109	11	cancer	cancer	NOUN
gra-1922	109	12	network	network	NOUN
gra-1922	109	13	guidelines	guideline	NOUN
gra-1922	109	14	,	,	PUNCT
gra-1922	109	15	based	base	VERB
gra-1922	109	16	on	on	ADP
gra-1922	109	17	the	the	DET
gra-1922	109	18	results	result	NOUN
gra-1922	109	19	of	of	ADP
gra-1922	109	20	5	5	NUM
gra-1922	109	21	randomized	randomized	ADJ
gra-1922	109	22	trials	trial	NOUN
gra-1922	109	23	[	[	X
gra-1922	109	24	4	4	NUM
gra-1922	109	25	-	-	NUM
gra-1922	109	26	9]conducted	9]conducte	VERB
gra-1922	109	27	during	during	ADP
gra-1922	109	28	the	the	DET
gra-1922	109	29	1990s	1990s	NUM
gra-1922	109	30	.	.	PUNCT
gra-1922	110	1	weekly	weekly	ADJ
gra-1922	110	2	smaller	small	ADJ
gra-1922	110	3	individual	individual	ADJ
gra-1922	110	4	doses	dose	NOUN
gra-1922	110	5	of	of	ADP
gra-1922	110	6	cisplatin	cisplatin	NOUN
gra-1922	110	7	may	may	AUX
gra-1922	110	8	lead	lead	VERB
gra-1922	110	9	to	to	ADP
gra-1922	110	10	less	less	ADJ
gra-1922	110	11	ct	ct	ADV
gra-1922	110	12	-	-	PUNCT
gra-1922	110	13	induced	induce	VERB
gra-1922	110	14	morbidity	morbidity	NOUN
gra-1922	110	15	without	without	ADP
gra-1922	110	16	compromising	compromise	VERB
gra-1922	110	17	efcacy	efcacy	NOUN
gra-1922	110	18	.	.	PUNCT
gra-1922	111	1	however	however	ADV
gra-1922	111	2	,	,	PUNCT
gra-1922	111	3	three	three	NUM
gra-1922	111	4	weekly	weekly	ADJ
gra-1922	111	5	cisplatin	cisplatin	NOUN
gra-1922	111	6	is	be	AUX
gra-1922	111	7	popular	popular	ADJ
gra-1922	111	8	in	in	ADP
gra-1922	111	9	head	head	NOUN
gra-1922	111	10	-	-	PUNCT
gra-1922	111	11	and	and	CCONJ
gra-1922	111	12	-	-	PUNCT
gra-1922	111	13	neck	neck	NOUN
gra-1922	111	14	cancers	cancer	NOUN
gra-1922	111	15	.	.	PUNCT
gra-1922	112	1	it	it	PRON
gra-1922	112	2	is	be	AUX
gra-1922	112	3	assumed	assume	VERB
gra-1922	112	4	that	that	SCONJ
gra-1922	112	5	high	high	ADJ
gra-1922	112	6	dose	dose	VERB
gra-1922	112	7	three	three	NUM
gra-1922	112	8	weekly	weekly	ADJ
gra-1922	112	9	cisplatin	cisplatin	NOUN
gra-1922	112	10	may	may	AUX
gra-1922	112	11	also	also	ADV
gra-1922	112	12	help	help	VERB
gra-1922	112	13	in	in	ADP
gra-1922	112	14	preventing	prevent	VERB
gra-1922	112	15	distant	distant	ADJ
gra-1922	112	16	metastasis	metastasis	NOUN
gra-1922	112	17	by	by	ADP
gra-1922	112	18	neutralising	neutralise	VERB
gra-1922	112	19	occult	occult	NOUN
gra-1922	112	20	[	[	X
gra-1922	112	21	15	15	NUM
gra-1922	112	22	]	]	PUNCT
gra-1922	112	23	micrometastasis	micrometastasis	NOUN
gra-1922	112	24	apart	apart	ADV
gra-1922	112	25	from	from	ADP
gra-1922	112	26	radiosensitisation	radiosensitisation	NOUN
gra-1922	112	27	.	.	PUNCT
gra-1922	113	1	ryu	ryu	PROPN
gra-1922	113	2	et	et	PROPN
gra-1922	113	3	al	al	PROPN
gra-1922	113	4	in	in	ADP
gra-1922	113	5	their	their	PRON
gra-1922	113	6	randomized	randomized	ADJ
gra-1922	113	7	trial	trial	NOUN
gra-1922	113	8	using	use	VERB
gra-1922	113	9	triweekly	triweekly	ADJ
gra-1922	113	10	single	single	ADJ
gra-1922	113	11	cddp	cddp	PROPN
gra-1922	113	12	chemotherapy	chemotherapy	NOUN
gra-1922	113	13	concurrent	concurrent	NOUN
gra-1922	113	14	with	with	ADP
gra-1922	113	15	rt	rt	PROPN
gra-1922	113	16	documented	document	VERB
gra-1922	113	17	better	well	ADJ
gra-1922	113	18	5	5	NUM
gra-1922	113	19	-	-	PUNCT
gra-1922	113	20	year	year	NOUN
gra-1922	113	21	survival	survival	NOUN
gra-1922	113	22	and	and	CCONJ
gra-1922	113	23	lower	low	ADJ
gra-1922	113	24	incidence	incidence	NOUN
gra-1922	113	25	of	of	ADP
gra-1922	113	26	hematological	hematological	ADJ
gra-1922	113	27	toxicity	toxicity	NOUN
gra-1922	113	28	compared	compare	VERB
gra-1922	113	29	with	with	ADP
gra-1922	113	30	the	the	DET
gra-1922	113	31	conventional	conventional	ADJ
gra-1922	113	32	weekly	weekly	ADJ
gra-1922	113	33	cddp	cddp	NOUN
gra-1922	113	34	in	in	ADP
gra-1922	113	35	patients	patient	NOUN
gra-1922	113	36	with	with	ADP
gra-1922	113	37	[	[	X
gra-1922	113	38	11]lacc	11]lacc	NUM
gra-1922	113	39	.	.	PUNCT
gra-1922	114	1	in	in	ADP
gra-1922	114	2	the	the	DET
gra-1922	114	3	present	present	ADJ
gra-1922	114	4	study	study	NOUN
gra-1922	114	5	,	,	PUNCT
gra-1922	114	6	85	85	NUM
gra-1922	114	7	%	%	NOUN
gra-1922	114	8	and	and	CCONJ
gra-1922	114	9	92.5	92.5	NUM
gra-1922	114	10	%	%	NOUN
gra-1922	114	11	in	in	ADP
gra-1922	114	12	group	group	NOUN
gra-1922	114	13	1	1	NUM
gra-1922	114	14	and	and	CCONJ
gra-1922	114	15	group	group	NOUN
gra-1922	114	16	2	2	NUM
gra-1922	114	17	respectively	respectively	ADV
gra-1922	114	18	completed	complete	VERB
gra-1922	114	19	the	the	DET
gra-1922	114	20	full	full	ADJ
gra-1922	114	21	course	course	NOUN
gra-1922	114	22	of	of	ADP
gra-1922	114	23	chemotherapy	chemotherapy	NOUN
gra-1922	114	24	and	and	CCONJ
gra-1922	114	25	the	the	DET
gra-1922	114	26	most	most	ADV
gra-1922	114	27	common	common	ADJ
gra-1922	114	28	reason	reason	NOUN
gra-1922	114	29	for	for	ADP
gra-1922	114	30	incomplete	incomplete	ADJ
gra-1922	114	31	treatment	treatment	NOUN
gra-1922	114	32	was	be	AUX
gra-1922	114	33	haematologic	haematologic	ADJ
gra-1922	114	34	toxicity	toxicity	NOUN
gra-1922	114	35	.	.	PUNCT
gra-1922	115	1	these	these	DET
gra-1922	115	2	ndings	nding	NOUN
gra-1922	115	3	were	be	AUX
gra-1922	115	4	similar	similar	ADJ
gra-1922	115	5	to	to	PART
gra-1922	115	6	study	study	VERB
gra-1922	115	7	[	[	PUNCT
gra-1922	115	8	16]conducted	16]conducte	VERB
gra-1922	115	9	by	by	ADP
gra-1922	115	10	anusha	anusha	PROPN
gra-1922	115	11	et	et	PROPN
gra-1922	115	12	al	al	PROPN
gra-1922	115	13	.	.	PUNCT
gra-1922	116	1	however	however	ADV
gra-1922	116	2	in	in	ADP
gra-1922	116	3	another	another	DET
gra-1922	116	4	similar	similar	ADJ
gra-1922	116	5	study	study	NOUN
gra-1922	116	6	by	by	ADP
gra-1922	116	7	ryu	ryu	PROPN
gra-1922	116	8	et	et	PROPN
gra-1922	116	9	al	al	PROPN
gra-1922	116	10	,	,	PUNCT
gra-1922	116	11	the	the	DET
gra-1922	116	12	two	two	NUM
gra-1922	116	13	regimens	regimen	NOUN
gra-1922	116	14	were	be	AUX
gra-1922	116	15	tolerated	tolerate	VERB
gra-1922	116	16	very	very	ADV
gra-1922	116	17	well	well	ADV
gra-1922	116	18	,	,	PUNCT
gra-1922	116	19	with	with	ADP
gra-1922	116	20	86.3	86.3	NUM
gra-1922	116	21	%	%	NOUN
gra-1922	116	22	and	and	CCONJ
gra-1922	116	23	92.5	92.5	NUM
gra-1922	116	24	%	%	NOUN
gra-1922	116	25	completion	completion	NOUN
gra-1922	116	26	of	of	ADP
gra-1922	116	27	scheduled	schedule	VERB
gra-1922	116	28	ct	ct	NUM
gra-1922	116	29	cycles	cycle	NOUN
gra-1922	116	30	for	for	ADP
gra-1922	116	31	[	[	PUNCT
gra-1922	116	32	11]the	11]the	PRON
gra-1922	116	33	weekly	weekly	ADJ
gra-1922	116	34	and	and	CCONJ
gra-1922	116	35	triweekly	triweekly	ADJ
gra-1922	116	36	arms	arm	NOUN
gra-1922	116	37	,	,	PUNCT
gra-1922	116	38	respectively	respectively	ADV
gra-1922	116	39	.	.	PUNCT
gra-1922	117	1	the	the	DET
gra-1922	117	2	present	present	ADJ
gra-1922	117	3	study	study	NOUN
gra-1922	117	4	observed	observe	VERB
gra-1922	117	5	neutropenia	neutropenia	NOUN
gra-1922	117	6	and	and	CCONJ
gra-1922	117	7	gi	gi	VERB
gra-1922	117	8	toxicities	toxicity	NOUN
gra-1922	117	9	as	as	ADP
gra-1922	117	10	the	the	DET
gra-1922	117	11	most	most	ADV
gra-1922	117	12	common	common	ADJ
gra-1922	117	13	acute	acute	ADJ
gra-1922	117	14	toxicities	toxicity	NOUN
gra-1922	117	15	,	,	PUNCT
gra-1922	117	16	however	however	ADV
gra-1922	117	17	,	,	PUNCT
gra-1922	117	18	no	no	DET
gra-1922	117	19	statistically	statistically	ADV
gra-1922	117	20	signicant	signicant	ADJ
gra-1922	117	21	difference	difference	NOUN
gra-1922	117	22	was	be	AUX
gra-1922	117	23	observed	observe	VERB
gra-1922	117	24	for	for	ADP
gra-1922	117	25	any	any	DET
gra-1922	117	26	toxicities	toxicity	NOUN
gra-1922	117	27	between	between	ADP
gra-1922	117	28	the	the	DET
gra-1922	117	29	participants	participant	NOUN
gra-1922	117	30	of	of	ADP
gra-1922	117	31	2	2	NUM
gra-1922	117	32	groups	group	NOUN
gra-1922	117	33	(	(	PUNCT
gra-1922	117	34	p>0.05	p>0.05	PROPN
gra-1922	117	35	)	)	PUNCT
gra-1922	117	36	.	.	PUNCT
gra-1922	118	1	nauseas	nausea	NOUN
gra-1922	118	2	was	be	AUX
gra-1922	118	3	reported	report	VERB
gra-1922	118	4	by	by	ADP
gra-1922	118	5	all	all	DET
gra-1922	118	6	the	the	DET
gra-1922	118	7	patients	patient	NOUN
gra-1922	118	8	in	in	ADP
gra-1922	118	9	both	both	CCONJ
gra-1922	118	10	the	the	DET
gra-1922	118	11	groups	group	NOUN
gra-1922	118	12	.	.	PUNCT
gra-1922	119	1	these	these	DET
gra-1922	119	2	ndings	nding	NOUN
gra-1922	119	3	were	be	AUX
gra-1922	119	4	[	[	PUNCT
gra-1922	119	5	16,11]supported	16,11]supporte	VERB
gra-1922	119	6	by	by	ADP
gra-1922	119	7	anusha	anusha	PROPN
gra-1922	119	8	et	et	PROPN
gra-1922	119	9	al	al	PROPN
gra-1922	119	10	and	and	CCONJ
gra-1922	119	11	ryu	ryu	PROPN
gra-1922	119	12	et	et	PROPN
gra-1922	119	13	al	al	PROPN
gra-1922	119	14	.	.	PUNCT
gra-1922	120	1	however	however	ADV
gra-1922	120	2	,	,	PUNCT
gra-1922	120	3	lee	lee	PROPN
gra-1922	120	4	et	et	PROPN
gra-1922	120	5	al	al	PROPN
gra-1922	120	6	documented	document	VERB
gra-1922	120	7	contrasting	contrast	VERB
gra-1922	120	8	results	result	NOUN
gra-1922	120	9	in	in	ADP
gra-1922	120	10	which	which	PRON
gra-1922	120	11	tri	tri	ADJ
gra-1922	120	12	weekly	weekly	ADJ
gra-1922	120	13	cisplatin	cisplatin	NOUN
gra-1922	120	14	was	be	AUX
gra-1922	120	15	associated	associate	VERB
gra-1922	120	16	with	with	ADP
gra-1922	120	17	higher	high	ADJ
gra-1922	120	18	incidence	incidence	NOUN
gra-1922	120	19	of	of	ADP
gra-1922	120	20	leucopenia	leucopenia	NOUN
gra-1922	120	21	(	(	PUNCT
gra-1922	120	22	96	96	NUM
gra-1922	120	23	%	%	NOUN
gra-1922	120	24	)	)	PUNCT
gra-1922	120	25	as	as	ADP
gra-1922	120	26	[	[	X
gra-1922	120	27	12	12	NUM
gra-1922	120	28	]	]	PUNCT
gra-1922	120	29	compared	compare	VERB
gra-1922	120	30	to	to	ADP
gra-1922	120	31	weekly	weekly	ADJ
gra-1922	120	32	cisplatin	cisplatin	NOUN
gra-1922	120	33	group	group	NOUN
gra-1922	120	34	(	(	PUNCT
gra-1922	120	35	85	85	NUM
gra-1922	120	36	%	%	NOUN
gra-1922	120	37	)	)	PUNCT
gra-1922	120	38	.	.	PUNCT
gra-1922	121	1	prolonged	prolonged	ADJ
gra-1922	121	2	treatment	treatment	NOUN
gra-1922	121	3	time	time	NOUN
gra-1922	121	4	had	have	VERB
gra-1922	121	5	an	an	DET
gra-1922	121	6	adverse	adverse	ADJ
gra-1922	121	7	effect	effect	NOUN
gra-1922	121	8	on	on	ADP
gra-1922	121	9	outcome	outcome	NOUN
gra-1922	121	10	because	because	SCONJ
gra-1922	121	11	of	of	ADP
gra-1922	121	12	accelerated	accelerate	VERB
gra-1922	121	13	repopulation	repopulation	NOUN
gra-1922	121	14	of	of	ADP
gra-1922	121	15	tumor	tumor	NOUN
gra-1922	121	16	and	and	CCONJ
gra-1922	121	17	thus	thus	ADV
gra-1922	121	18	any	any	DET
gra-1922	121	19	delays	delay	NOUN
gra-1922	121	20	must	must	AUX
gra-1922	121	21	[	[	X
gra-1922	121	22	16]be	16]be	NUM
gra-1922	121	23	avoided	avoid	VERB
gra-1922	121	24	.	.	PUNCT
gra-1922	122	1	at	at	ADP
gra-1922	122	2	6	6	NUM
gra-1922	122	3	weeks	week	NOUN
gra-1922	122	4	,	,	PUNCT
gra-1922	122	5	following	follow	VERB
gra-1922	122	6	treatment	treatment	NOUN
gra-1922	122	7	,	,	PUNCT
gra-1922	122	8	complete	complete	ADJ
gra-1922	122	9	response	response	NOUN
gra-1922	122	10	was	be	AUX
gra-1922	122	11	observed	observe	VERB
gra-1922	122	12	in	in	ADP
gra-1922	122	13	82.5	82.5	NUM
gra-1922	122	14	%	%	NOUN
gra-1922	122	15	and	and	CCONJ
gra-1922	122	16	90	90	NUM
gra-1922	122	17	%	%	NOUN
gra-1922	122	18	patients	patient	NOUN
gra-1922	122	19	in	in	ADP
gra-1922	122	20	group	group	NOUN
gra-1922	122	21	1	1	NUM
gra-1922	122	22	and	and	CCONJ
gra-1922	122	23	group	group	NOUN
gra-1922	122	24	2	2	NUM
gra-1922	122	25	respectively	respectively	ADV
gra-1922	122	26	in	in	ADP
gra-1922	122	27	present	present	ADJ
gra-1922	122	28	study	study	NOUN
gra-1922	122	29	.	.	PUNCT
gra-1922	123	1	these	these	DET
gra-1922	123	2	nding	nding	NOUN
gra-1922	123	3	were	be	AUX
gra-1922	123	4	similar	similar	ADJ
gra-1922	123	5	to	to	ADP
gra-1922	123	6	the	the	DET
gra-1922	123	7	ndings	nding	NOUN
gra-1922	123	8	reported	report	VERB
gra-1922	123	9	by	by	ADP
gra-1922	123	10	anusha	anusha	PROPN
gra-1922	123	11	et	et	PROPN
gra-1922	123	12	al	al	PROPN
gra-1922	123	13	in	in	ADP
gra-1922	123	14	which	which	PRON
gra-1922	123	15	complete	complete	ADJ
gra-1922	123	16	response	response	NOUN
gra-1922	123	17	was	be	AUX
gra-1922	123	18	seen	see	VERB
gra-1922	123	19	in	in	ADP
gra-1922	123	20	17	17	NUM
gra-1922	123	21	(	(	PUNCT
gra-1922	123	22	85	85	NUM
gra-1922	123	23	%	%	NOUN
gra-1922	123	24	)	)	PUNCT
gra-1922	123	25	patients	patient	NOUN
gra-1922	123	26	of	of	ADP
gra-1922	123	27	arm	arm	NOUN
gra-1922	123	28	a	a	PRON
gra-1922	123	29	,	,	PUNCT
gra-1922	123	30	19	19	NUM
gra-1922	123	31	(	(	PUNCT
gra-1922	123	32	95	95	NUM
gra-1922	123	33	%	%	NOUN
gra-1922	123	34	)	)	PUNCT
gra-1922	123	35	patients	patient	NOUN
gra-1922	123	36	of	of	ADP
gra-1922	123	37	[	[	X
gra-1922	123	38	16]arm	16]arm	PROPN
gra-1922	123	39	b.	b.	PROPN
gra-1922	123	40	the	the	DET
gra-1922	123	41	reference	reference	NOUN
gra-1922	123	42	study	study	NOUN
gra-1922	123	43	and	and	CCONJ
gra-1922	123	44	present	present	ADJ
gra-1922	123	45	study	study	NOUN
gra-1922	123	46	observed	observe	VERB
gra-1922	123	47	no	no	DET
gra-1922	123	48	statistically	statistically	ADV
gra-1922	123	49	signicant	signicant	ADJ
gra-1922	123	50	difference	difference	NOUN
gra-1922	123	51	in	in	ADP
gra-1922	123	52	treatment	treatment	NOUN
gra-1922	123	53	response	response	NOUN
gra-1922	123	54	between	between	ADP
gra-1922	123	55	two	two	NUM
gra-1922	123	56	groups	group	NOUN
gra-1922	123	57	.	.	PUNCT
gra-1922	124	1	however	however	ADV
gra-1922	124	2	,	,	PUNCT
gra-1922	124	3	ryu	ryu	PROPN
gra-1922	124	4	et	et	PROPN
gra-1922	124	5	al	al	PROPN
gra-1922	124	6	documented	document	VERB
gra-1922	124	7	better	well	ADJ
gra-1922	124	8	survival	survival	NOUN
gra-1922	124	9	rate	rate	NOUN
gra-1922	124	10	in	in	ADP
gra-1922	124	11	patients	patient	NOUN
gra-1922	124	12	in	in	ADP
gra-1922	124	13	88.7	88.7	NUM
gra-1922	124	14	%	%	NOUN
gra-1922	124	15	cases	case	NOUN
gra-1922	124	16	with	with	ADP
gra-1922	124	17	tri	tri	ADJ
gra-1922	124	18	weekly	weekly	ADJ
gra-1922	124	19	cisplatin	cisplatin	NOUN
gra-1922	124	20	at	at	ADP
gra-1922	124	21	5	5	NUM
gra-1922	124	22	years	year	NOUN
gra-1922	124	23	versus	versus	ADP
gra-1922	124	24	66.7	66.7	NUM
gra-1922	124	25	%	%	NOUN
gra-1922	124	26	for	for	ADP
gra-1922	124	27	the	the	DET
gra-1922	124	28	weekly	weekly	ADJ
gra-1922	124	29	cisplatin	cisplatin	NOUN
gra-1922	125	1	[	[	X
gra-1922	125	2	11]arm	11]arm	X
gra-1922	125	3	.	.	PUNCT
gra-1922	126	1	conclusionthe	conclusionthe	PROPN
gra-1922	126	2	present	present	ADJ
gra-1922	126	3	study	study	NOUN
gra-1922	126	4	documented	document	VERB
gra-1922	126	5	similar	similar	ADJ
gra-1922	126	6	response	response	NOUN
gra-1922	126	7	and	and	CCONJ
gra-1922	126	8	toxicity	toxicity	NOUN
gra-1922	126	9	prole	prole	PROPN
gra-1922	126	10	of	of	ADP
gra-1922	126	11	both	both	CCONJ
gra-1922	126	12	the	the	DET
gra-1922	126	13	regimens	regimen	NOUN
gra-1922	126	14	and	and	CCONJ
gra-1922	126	15	thus	thus	ADV
gra-1922	126	16	concurrent	concurrent	ADJ
gra-1922	126	17	weekly	weekly	NOUN
gra-1922	126	18	or	or	CCONJ
gra-1922	126	19	3	3	NUM
gra-1922	126	20	weekly	weekly	ADJ
gra-1922	126	21	cisplatin	cisplatin	NOUN
gra-1922	126	22	along	along	ADP
gra-1922	126	23	with	with	ADP
gra-1922	126	24	radiotherapy	radiotherapy	NOUN
gra-1922	126	25	can	can	AUX
gra-1922	126	26	be	be	AUX
gra-1922	126	27	used	use	VERB
gra-1922	126	28	with	with	ADP
gra-1922	126	29	equal	equal	ADJ
gra-1922	126	30	effectiveness	effectiveness	NOUN
gra-1922	126	31	in	in	ADP
gra-1922	126	32	the	the	DET
gra-1922	126	33	treatment	treatment	NOUN
gra-1922	126	34	of	of	ADP
gra-1922	126	35	cervical	cervical	ADJ
gra-1922	126	36	cancer	cancer	NOUN
gra-1922	126	37	.	.	PUNCT
gra-1922	127	1	long	long	ADJ
gra-1922	127	2	term	term	NOUN
gra-1922	127	3	follow	follow	VERB
gra-1922	127	4	up	up	ADP
gra-1922	127	5	of	of	ADP
gra-1922	127	6	these	these	DET
gra-1922	127	7	patients	patient	NOUN
gra-1922	127	8	is	be	AUX
gra-1922	127	9	needed	need	VERB
gra-1922	127	10	to	to	PART
gra-1922	127	11	reach	reach	VERB
gra-1922	127	12	any	any	DET
gra-1922	127	13	denite	denite	ADJ
gra-1922	127	14	conclusion	conclusion	NOUN
gra-1922	127	15	regarding	regard	VERB
gra-1922	127	16	its	its	PRON
gra-1922	127	17	effect	effect	NOUN
gra-1922	127	18	on	on	ADP
gra-1922	127	19	overall	overall	ADJ
gra-1922	127	20	survival	survival	NOUN
gra-1922	127	21	.	.	PUNCT
gra-1922	128	1	references	reference	NOUN
gra-1922	128	2	1	1	NUM
gra-1922	128	3	.	.	PUNCT
gra-1922	129	1	who	who	PRON
gra-1922	129	2	.	.	PUNCT
gra-1922	130	1	cancer	cancer	NOUN
gra-1922	130	2	cervix	cervix	NOUN
gra-1922	130	3	2018	2018	NUM
gra-1922	131	1	[	[	X
gra-1922	131	2	available	available	ADJ
gra-1922	131	3	from	from	ADP
gra-1922	131	4	:	:	PUNCT
gra-1922	131	5	https://www.who.int/	https://www.who.int/	NOUN
gra-1922	131	6	cancer	cancer	NOUN
gra-1922	131	7	/	/	SYM
gra-1922	131	8	prevention/	prevention/	NUM
gra-1922	131	9	diagnosis	diagnosis	NOUN
gra-1922	131	10	-	-	PUNCT
gra-1922	131	11	screening	screening	NOUN
gra-1922	131	12	/	/	SYM
gra-1922	131	13	cervical	cervical	ADJ
gra-1922	131	14	-	-	PUNCT
gra-1922	131	15	cancer	cancer	NOUN
gra-1922	131	16	/	/	SYM
gra-1922	131	17	en/.	en/.	VERB
gra-1922	131	18	accessed	access	VERB
gra-1922	131	19	on	on	ADP
gra-1922	131	20	10	10	NUM
gra-1922	131	21	february	february	NOUN
gra-1922	131	22	2020	2020	NUM
gra-1922	131	23	.	.	PUNCT
gra-1922	132	1	2	2	NUM
gra-1922	132	2	.	.	NOUN
gra-1922	132	3	arbyn	arbyn	PROPN
gra-1922	132	4	m	m	PROPN
gra-1922	132	5	,	,	PUNCT
gra-1922	132	6	weiderpass	weiderpass	ADJ
gra-1922	132	7	e	e	NOUN
gra-1922	132	8	,	,	PUNCT
gra-1922	132	9	bruni	bruni	PROPN
gra-1922	132	10	l	l	PROPN
gra-1922	132	11	,	,	PUNCT
gra-1922	132	12	de	de	PROPN
gra-1922	132	13	sanjosé	sanjosé	PROPN
gra-1922	132	14	s	s	PROPN
gra-1922	132	15	,	,	PUNCT
gra-1922	132	16	saraiya	saraiya	NOUN
gra-1922	132	17	m	m	PROPN
gra-1922	132	18	,	,	PUNCT
gra-1922	132	19	ferlay	ferlay	PROPN
gra-1922	132	20	j	j	PROPN
gra-1922	132	21	,	,	PUNCT
gra-1922	132	22	bray	bray	PROPN
gra-1922	132	23	f.	f.	PROPN
gra-1922	132	24	estimates	estimate	NOUN
gra-1922	132	25	of	of	ADP
gra-1922	132	26	incidence	incidence	NOUN
gra-1922	132	27	and	and	CCONJ
gra-1922	132	28	mortality	mortality	NOUN
gra-1922	132	29	of	of	ADP
gra-1922	132	30	cervical	cervical	ADJ
gra-1922	132	31	cancer	cancer	NOUN
gra-1922	132	32	in	in	ADP
gra-1922	132	33	2018	2018	NUM
gra-1922	132	34	:	:	PUNCT
gra-1922	132	35	a	a	DET
gra-1922	132	36	worldwide	worldwide	ADJ
gra-1922	132	37	analysis	analysis	NOUN
gra-1922	132	38	.	.	PUNCT
gra-1922	133	1	the	the	DET
gra-1922	133	2	lancet	lancet	PROPN
gra-1922	133	3	global	global	PROPN
gra-1922	133	4	health	health	NOUN
gra-1922	133	5	.	.	PUNCT
gra-1922	134	1	2020	2020	NUM
gra-1922	134	2	feb	feb	PROPN
gra-1922	134	3	1;8(2):e191	1;8(2):e191	NUM
gra-1922	134	4	-	-	PUNCT
gra-1922	134	5	203	203	NUM
gra-1922	134	6	.	.	PUNCT
gra-1922	134	7	3	3	X
gra-1922	134	8	.	.	X
gra-1922	134	9	tri	tri	ADJ
gra-1922	134	10	-	-	ADJ
gra-1922	134	11	weekly	weekly	ADJ
gra-1922	134	12	cisplatin	cisplatin	NOUN
gra-1922	134	13	based	base	VERB
gra-1922	134	14	chemoradiation	chemoradiation	NOUN
gra-1922	134	15	in	in	ADP
gra-1922	134	16	locally	locally	ADV
gra-1922	134	17	advanced	advance	VERB
gra-1922	134	18	cervical	cervical	ADJ
gra-1922	134	19	cancer	cancer	NOUN
gra-1922	134	20	https://www.centerwatch.com/clinical-trials/listings/163716/cervicalcancer-tri-weekly-cisplatin-based-chemoradiation/	https://www.centerwatch.com/clinical-trials/listings/163716/cervicalcancer-tri-weekly-cisplatin-based-chemoradiation/	NOUN
gra-1922	134	21	accessed	access	VERB
gra-1922	134	22	on	on	ADP
gra-1922	134	23	10	10	NUM
gra-1922	134	24	february	february	NOUN
gra-1922	134	25	2020	2020	NUM
gra-1922	134	26	.	.	PUNCT
gra-1922	135	1	4	4	X
gra-1922	135	2	.	.	X
gra-1922	135	3	whitney	whitney	PROPN
gra-1922	135	4	,	,	PUNCT
gra-1922	135	5	c.w	c.w	PROPN
gra-1922	135	6	.	.	PROPN
gra-1922	135	7	,	,	PUNCT
gra-1922	135	8	sause	sause	NOUN
gra-1922	135	9	,	,	PUNCT
gra-1922	135	10	w.	w.	PROPN
gra-1922	135	11	,	,	PUNCT
gra-1922	135	12	bundy	bundy	PROPN
gra-1922	135	13	,	,	PUNCT
gra-1922	135	14	b.n	b.n	PROPN
gra-1922	135	15	.	.	PROPN
gra-1922	135	16	,	,	PUNCT
gra-1922	135	17	malfetano	malfetano	PROPN
gra-1922	135	18	,	,	PUNCT
gra-1922	135	19	j.h	j.h	PROPN
gra-1922	135	20	.	.	PROPN
gra-1922	135	21	,	,	PUNCT
gra-1922	135	22	hannigan	hannigan	PROPN
gra-1922	135	23	,	,	PUNCT
gra-1922	135	24	e.v	e.v	PROPN
gra-1922	135	25	.	.	PROPN
gra-1922	135	26	,	,	PUNCT
gra-1922	135	27	fowler	fowler	PROPN
gra-1922	135	28	,	,	PUNCT
gra-1922	135	29	jr	jr	PROPN
gra-1922	135	30	,	,	PUNCT
gra-1922	135	31	w.c	w.c	PROPN
gra-1922	135	32	.	.	PROPN
gra-1922	135	33	,	,	PUNCT
gra-1922	135	34	clarke	clarke	PROPN
gra-1922	135	35	-	-	PUNCT
gra-1922	135	36	pearson	pearson	PROPN
gra-1922	135	37	,	,	PUNCT
gra-1922	135	38	d.l	d.l	PROPN
gra-1922	135	39	.	.	PROPN
gra-1922	135	40	and	and	CCONJ
gra-1922	135	41	liao	liao	PROPN
gra-1922	135	42	,	,	PUNCT
gra-1922	135	43	s.y	s.y	PROPN
gra-1922	135	44	.	.	PROPN
gra-1922	135	45	,	,	PUNCT
gra-1922	135	46	1999	1999	NUM
gra-1922	135	47	.	.	PUNCT
gra-1922	136	1	randomized	randomize	VERB
gra-1922	136	2	comparison	comparison	NOUN
gra-1922	136	3	of	of	ADP
gra-1922	136	4	uorouracil	uorouracil	PRON
gra-1922	136	5	plus	plus	CCONJ
gra-1922	136	6	cisplatin	cisplatin	NOUN
gra-1922	136	7	versus	versus	ADP
gra-1922	136	8	hydroxyurea	hydroxyurea	PROPN
gra-1922	136	9	as	as	ADP
gra-1922	136	10	an	an	DET
gra-1922	136	11	adjunct	adjunct	ADJ
gra-1922	136	12	to	to	ADP
gra-1922	136	13	radiation	radiation	NOUN
gra-1922	136	14	therapy	therapy	NOUN
gra-1922	136	15	in	in	ADP
gra-1922	136	16	stage	stage	NOUN
gra-1922	136	17	iib	iib	PROPN
gra-1922	136	18	-	-	PUNCT
gra-1922	136	19	iva	iva	PROPN
gra-1922	136	20	carcinoma	carcinoma	NOUN
gra-1922	136	21	of	of	ADP
gra-1922	136	22	the	the	DET
gra-1922	136	23	cervix	cervix	NOUN
gra-1922	136	24	with	with	ADP
gra-1922	136	25	negative	negative	ADJ
gra-1922	136	26	para	para	ADJ
gra-1922	136	27	-	-	PUNCT
gra-1922	136	28	aortic	aortic	ADJ
gra-1922	136	29	lymph	lymph	NOUN
gra-1922	136	30	nodes	nod	VERB
gra-1922	136	31	:	:	PUNCT
gra-1922	136	32	a	a	DET
gra-1922	136	33	gynecologic	gynecologic	ADJ
gra-1922	136	34	oncology	oncology	NOUN
gra-1922	136	35	group	group	NOUN
gra-1922	136	36	and	and	CCONJ
gra-1922	136	37	southwest	southwest	NOUN
gra-1922	136	38	oncology	oncology	NOUN
gra-1922	136	39	group	group	NOUN
gra-1922	136	40	study	study	NOUN
gra-1922	136	41	.	.	PUNCT
gra-1922	137	1	journal	journal	NOUN
gra-1922	137	2	of	of	ADP
gra-1922	137	3	clinical	clinical	ADJ
gra-1922	137	4	oncology	oncology	NOUN
gra-1922	137	5	,	,	PUNCT
gra-1922	137	6	17(5	17(5	NUM
gra-1922	137	7	)	)	PUNCT
gra-1922	137	8	,	,	PUNCT
gra-1922	137	9	pp.1339	pp.1339	PROPN
gra-1922	137	10	-	-	SYM
gra-1922	137	11	1339	1339	NUM
gra-1922	137	12	.	.	PUNCT
gra-1922	138	1	5	5	NUM
gra-1922	138	2	.	.	X
gra-1922	138	3	rose	rise	VERB
gra-1922	138	4	pg	pg	PROPN
gra-1922	138	5	,	,	PUNCT
gra-1922	138	6	bundy	bundy	PROPN
gra-1922	138	7	bn	bn	PROPN
gra-1922	138	8	,	,	PUNCT
gra-1922	138	9	watkins	watkins	PROPN
gra-1922	138	10	eb	eb	PROPN
gra-1922	138	11	,	,	PUNCT
gra-1922	138	12	thigpen	thigpen	PROPN
gra-1922	138	13	jt	jt	PROPN
gra-1922	138	14	,	,	PUNCT
gra-1922	138	15	deppe	deppe	PROPN
gra-1922	138	16	g	g	NOUN
gra-1922	138	17	,	,	PUNCT
gra-1922	138	18	maiman	maiman	PROPN
gra-1922	138	19	ma	ma	PROPN
gra-1922	138	20	,	,	PUNCT
gra-1922	138	21	et	et	PROPN
gra-1922	138	22	al	al	PROPN
gra-1922	138	23	.	.	PUNCT
gra-1922	139	1	concurrent	concurrent	ADJ
gra-1922	139	2	cisplatin	cisplatin	NOUN
gra-1922	139	3	-	-	PUNCT
gra-1922	139	4	based	base	VERB
gra-1922	139	5	radiotherapy	radiotherapy	NOUN
gra-1922	139	6	and	and	CCONJ
gra-1922	139	7	chemotherapy	chemotherapy	NOUN
gra-1922	139	8	for	for	ADP
gra-1922	139	9	locally	locally	ADV
gra-1922	139	10	advanced	advanced	ADJ
gra-1922	139	11	cervical	cervical	ADJ
gra-1922	139	12	cancer	cancer	NOUN
gra-1922	139	13	.	.	PUNCT
gra-1922	140	1	n	n	PROPN
gra-1922	140	2	engl	engl	PROPN
gra-1922	140	3	j	j	PROPN
gra-1922	140	4	med	me	VERB
gra-1922	140	5	1999;340:1144	1999;340:1144	NUM
gra-1922	140	6	-	-	SYM
gra-1922	140	7	53	53	NUM
gra-1922	140	8	.	.	NOUN
gra-1922	141	1	6	6	NUM
gra-1922	141	2	.	.	X
gra-1922	141	3	morris	morris	PROPN
gra-1922	141	4	m	m	PROPN
gra-1922	141	5	,	,	PUNCT
gra-1922	141	6	eifel	eifel	PROPN
gra-1922	141	7	pj	pj	PROPN
gra-1922	141	8	,	,	PUNCT
gra-1922	141	9	lu	lu	PROPN
gra-1922	141	10	j	j	PROPN
gra-1922	141	11	,	,	PUNCT
gra-1922	141	12	grigsby	grigsby	PROPN
gra-1922	141	13	pw	pw	PROPN
gra-1922	141	14	,	,	PUNCT
gra-1922	141	15	levenback	levenback	PROPN
gra-1922	141	16	c	c	PROPN
gra-1922	141	17	,	,	PUNCT
gra-1922	141	18	stevens	stevens	PROPN
gra-1922	141	19	re	re	PROPN
gra-1922	141	20	,	,	PUNCT
gra-1922	141	21	et	et	PROPN
gra-1922	141	22	al	al	PROPN
gra-1922	141	23	.	.	PUNCT
gra-1922	142	1	pelvic	pelvic	ADJ
gra-1922	142	2	radiation	radiation	NOUN
gra-1922	142	3	with	with	ADP
gra-1922	142	4	concurrent	concurrent	ADJ
gra-1922	142	5	chemotherapy	chemotherapy	NOUN
gra-1922	142	6	compared	compare	VERB
gra-1922	142	7	with	with	ADP
gra-1922	142	8	pelvic	pelvic	ADJ
gra-1922	142	9	and	and	CCONJ
gra-1922	142	10	paraaortic	paraaortic	ADJ
gra-1922	142	11	radiation	radiation	NOUN
gra-1922	142	12	for	for	ADP
gra-1922	142	13	high	high	ADJ
gra-1922	142	14	-	-	PUNCT
gra-1922	142	15	risk	risk	NOUN
gra-1922	142	16	cervical	cervical	ADJ
gra-1922	142	17	cancer	cancer	NOUN
gra-1922	142	18	.	.	PUNCT
gra-1922	143	1	n	n	PROPN
gra-1922	143	2	engl	engl	PROPN
gra-1922	143	3	j	j	PROPN
gra-1922	143	4	med	me	VERB
gra-1922	143	5	1999;340:1137	1999;340:1137	NUM
gra-1922	143	6	-	-	SYM
gra-1922	143	7	43	43	NUM
gra-1922	143	8	.	.	PUNCT
gra-1922	144	1	7	7	X
gra-1922	144	2	.	.	X
gra-1922	144	3	keys	key	NOUN
gra-1922	144	4	hm	hm	INTJ
gra-1922	144	5	,	,	PUNCT
gra-1922	144	6	bundy	bundy	PROPN
gra-1922	144	7	bn	bn	PROPN
gra-1922	144	8	,	,	PUNCT
gra-1922	144	9	stehman	stehman	NOUN
gra-1922	144	10	fb	fb	NOUN
gra-1922	144	11	,	,	PUNCT
gra-1922	144	12	muderspach	muderspach	PROPN
gra-1922	144	13	li	li	PROPN
gra-1922	144	14	,	,	PUNCT
gra-1922	144	15	chafe	chafe	VERB
gra-1922	144	16	we	we	PRON
gra-1922	144	17	,	,	PUNCT
gra-1922	144	18	suggs	suggs	PROPN
gra-1922	144	19	cl	cl	NOUN
gra-1922	144	20	3rd	3rd	NOUN
gra-1922	144	21	,	,	PUNCT
gra-1922	144	22	et	et	PROPN
gra-1922	144	23	al	al	PROPN
gra-1922	144	24	.	.	PROPN
gra-1922	144	25	cisplatin	cisplatin	NOUN
gra-1922	144	26	,	,	PUNCT
gra-1922	144	27	radiation	radiation	NOUN
gra-1922	144	28	,	,	PUNCT
gra-1922	144	29	and	and	CCONJ
gra-1922	144	30	adjuvant	adjuvant	ADJ
gra-1922	144	31	hysterectomy	hysterectomy	NOUN
gra-1922	144	32	compared	compare	VERB
gra-1922	144	33	with	with	ADP
gra-1922	144	34	radiation	radiation	NOUN
gra-1922	144	35	and	and	CCONJ
gra-1922	144	36	adjuvant	adjuvant	ADJ
gra-1922	144	37	hysterectomy	hysterectomy	NOUN
gra-1922	144	38	for	for	ADP
gra-1922	144	39	bulky	bulky	ADJ
gra-1922	144	40	stage	stage	NOUN
gra-1922	144	41	ib	ib	X
gra-1922	144	42	cervical	cervical	ADJ
gra-1922	144	43	carcinoma	carcinoma	NOUN
gra-1922	144	44	.	.	PUNCT
gra-1922	145	1	n	n	CCONJ
gra-1922	145	2	engl	engl	PROPN
gra-1922	145	3	j	j	PROPN
gra-1922	145	4	med	me	VERB
gra-1922	145	5	1999;340:1154	1999;340:1154	NUM
gra-1922	145	6	-	-	SYM
gra-1922	145	7	61	61	NUM
gra-1922	145	8	.	.	NOUN
gra-1922	145	9	8	8	NUM
gra-1922	145	10	.	.	PUNCT
gra-1922	146	1	peters	peters	PROPN
gra-1922	146	2	wa	wa	PROPN
gra-1922	146	3	3rd	3rd	PROPN
gra-1922	146	4	,	,	PUNCT
gra-1922	146	5	liu	liu	PROPN
gra-1922	146	6	py	py	PROPN
gra-1922	146	7	,	,	PUNCT
gra-1922	146	8	barrett	barrett	PROPN
gra-1922	146	9	rj	rj	PROPN
gra-1922	146	10	2nd	2nd	PROPN
gra-1922	146	11	,	,	PUNCT
gra-1922	146	12	stock	stock	PROPN
gra-1922	146	13	rj	rj	PROPN
gra-1922	146	14	,	,	PUNCT
gra-1922	146	15	monk	monk	NOUN
gra-1922	146	16	bj	bj	PROPN
gra-1922	146	17	,	,	PUNCT
gra-1922	146	18	berek	berek	PROPN
gra-1922	146	19	js	js	PROPN
gra-1922	146	20	,	,	PUNCT
gra-1922	146	21	et	et	PROPN
gra-1922	146	22	al	al	PROPN
gra-1922	146	23	.	.	PUNCT
gra-1922	146	24	concurrent	concurrent	ADJ
gra-1922	146	25	chemotherapy	chemotherapy	NOUN
gra-1922	146	26	and	and	CCONJ
gra-1922	146	27	pelvic	pelvic	ADJ
gra-1922	146	28	radiation	radiation	NOUN
gra-1922	146	29	therapy	therapy	NOUN
gra-1922	146	30	compared	compare	VERB
gra-1922	146	31	with	with	ADP
gra-1922	146	32	pelvic	pelvic	ADJ
gra-1922	146	33	radiation	radiation	NOUN
gra-1922	146	34	therapy	therapy	NOUN
gra-1922	146	35	alone	alone	ADV
gra-1922	146	36	as	as	ADP
gra-1922	146	37	adjuvant	adjuvant	ADJ
gra-1922	146	38	therapy	therapy	NOUN
gra-1922	146	39	after	after	ADP
gra-1922	146	40	radical	radical	ADJ
gra-1922	146	41	surgery	surgery	NOUN
gra-1922	146	42	in	in	ADP
gra-1922	146	43	high	high	ADJ
gra-1922	146	44	-	-	PUNCT
gra-1922	146	45	risk	risk	NOUN
gra-1922	146	46	early	early	ADJ
gra-1922	146	47	-	-	PUNCT
gra-1922	146	48	stage	stage	NOUN
gra-1922	146	49	cancer	cancer	NOUN
gra-1922	146	50	of	of	ADP
gra-1922	146	51	the	the	DET
gra-1922	146	52	cervix	cervix	NOUN
gra-1922	146	53	.	.	PUNCT
gra-1922	147	1	j	j	PROPN
gra-1922	147	2	clin	clin	PROPN
gra-1922	147	3	oncol	oncol	PROPN
gra-1922	147	4	2000;18:1606	2000;18:1606	NUM
gra-1922	147	5	-	-	SYM
gra-1922	147	6	13	13	NUM
gra-1922	147	7	.	.	NOUN
gra-1922	147	8	9	9	NUM
gra-1922	147	9	.	.	X
gra-1922	148	1	nci	nci	PROPN
gra-1922	148	2	clinical	clinical	ADJ
gra-1922	148	3	announcement	announcement	NOUN
gra-1922	148	4	.	.	PUNCT
gra-1922	149	1	concurrent	concurrent	ADJ
gra-1922	149	2	chemoradiation	chemoradiation	NOUN
gra-1922	149	3	for	for	ADP
gra-1922	149	4	cervical	cervical	ADJ
gra-1922	149	5	cancer	cancer	NOUN
gra-1922	149	6	(	(	PUNCT
gra-1922	149	7	report	report	NOUN
gra-1922	149	8	)	)	PUNCT
gra-1922	149	9	.	.	PUNCT
gra-1922	150	1	u.s	u.s	PROPN
gra-1922	150	2	.	.	PROPN
gra-1922	150	3	department	department	PROPN
gra-1922	150	4	of	of	ADP
gra-1922	150	5	public	public	ADJ
gra-1922	150	6	health	health	NOUN
gra-1922	150	7	;	;	PUNCT
gra-1922	150	8	1999	1999	NUM
gra-1922	150	9	.	.	PUNCT
gra-1922	151	1	10	10	NUM
gra-1922	151	2	.	.	X
gra-1922	151	3	tri	tri	ADJ
gra-1922	151	4	-	-	ADJ
gra-1922	151	5	weekly	weekly	ADJ
gra-1922	151	6	cisplatin	cisplatin	NOUN
gra-1922	151	7	based	base	VERB
gra-1922	151	8	chemoradiation	chemoradiation	NOUN
gra-1922	151	9	in	in	ADP
gra-1922	151	10	locally	locally	ADV
gra-1922	151	11	advanced	advance	VERB
gra-1922	151	12	cervical	cervical	ADJ
gra-1922	151	13	cancer	cancer	NOUN
gra-1922	151	14	(	(	PUNCT
gra-1922	151	15	taco	taco	NOUN
gra-1922	151	16	)	)	PUNCT
gra-1922	151	17	https://clinicaltrials.gov/ct2/show/nct01561586	https://clinicaltrials.gov/ct2/show/nct01561586	PUNCT
gra-1922	151	18	accessed	access	VERB
gra-1922	151	19	on	on	ADP
gra-1922	151	20	10	10	NUM
gra-1922	151	21	feb	feb	NOUN
gra-1922	151	22	2020	2020	NUM
gra-1922	151	23	.	.	PUNCT
gra-1922	152	1	11	11	NUM
gra-1922	152	2	.	.	PUNCT
gra-1922	153	1	ryu	ryu	PROPN
gra-1922	153	2	sy	sy	PROPN
gra-1922	153	3	,	,	PUNCT
gra-1922	153	4	lee	lee	PROPN
gra-1922	153	5	wm	wm	PROPN
gra-1922	153	6	,	,	PUNCT
gra-1922	153	7	kim	kim	PROPN
gra-1922	153	8	k	k	PROPN
gra-1922	153	9	,	,	PUNCT
gra-1922	153	10	park	park	NOUN
gra-1922	153	11	si	si	PROPN
gra-1922	153	12	,	,	PUNCT
gra-1922	153	13	kim	kim	PROPN
gra-1922	153	14	bj	bj	PROPN
gra-1922	153	15	,	,	PUNCT
gra-1922	153	16	kim	kim	PROPN
gra-1922	153	17	mh	mh	PROPN
gra-1922	153	18	,	,	PUNCT
gra-1922	153	19	et	et	PROPN
gra-1922	153	20	al	al	PROPN
gra-1922	153	21	.	.	PROPN
gra-1922	153	22	randomized	randomize	VERB
gra-1922	153	23	clinical	clinical	ADJ
gra-1922	153	24	trial	trial	NOUN
gra-1922	153	25	of	of	ADP
gra-1922	153	26	weekly	weekly	ADJ
gra-1922	153	27	vs.	vs.	ADP
gra-1922	153	28	triweekly	triweekly	NOUN
gra-1922	153	29	cisplatin	cisplatin	NOUN
gra-1922	153	30	-	-	PUNCT
gra-1922	153	31	based	base	VERB
gra-1922	153	32	chemotherapy	chemotherapy	NOUN
gra-1922	153	33	concurrent	concurrent	NOUN
gra-1922	153	34	with	with	ADP
gra-1922	153	35	radiotherapy	radiotherapy	NOUN
gra-1922	153	36	in	in	ADP
gra-1922	153	37	the	the	DET
gra-1922	153	38	treatment	treatment	NOUN
gra-1922	153	39	of	of	ADP
gra-1922	153	40	locally	locally	ADV
gra-1922	153	41	advanced	advanced	ADJ
gra-1922	153	42	cervical	cervical	ADJ
gra-1922	153	43	cancer	cancer	NOUN
gra-1922	153	44	.	.	PUNCT
gra-1922	154	1	int	int	PROPN
gra-1922	154	2	j	j	PROPN
gra-1922	154	3	radiat	radiat	PROPN
gra-1922	154	4	oncol	oncol	ADJ
gra-1922	154	5	biol	biol	PROPN
gra-1922	154	6	phys	phy	NOUN
gra-1922	154	7	2011;81	2011;81	NUM
gra-1922	154	8	:	:	PUNCT
gra-1922	154	9	e577	e577	PROPN
gra-1922	154	10	-	-	PUNCT
gra-1922	154	11	81	81	NUM
gra-1922	154	12	.	.	PUNCT
gra-1922	154	13	12	12	NUM
gra-1922	154	14	.	.	PUNCT
gra-1922	155	1	lee	lee	PROPN
gra-1922	155	2	hn	hn	PROPN
gra-1922	155	3	,	,	PUNCT
gra-1922	155	4	lee	lee	PROPN
gra-1922	155	5	kh	kh	PROPN
gra-1922	155	6	,	,	PUNCT
gra-1922	155	7	lee	lee	PROPN
gra-1922	155	8	dw	dw	PROPN
gra-1922	155	9	,	,	PUNCT
gra-1922	155	10	lee	lee	PROPN
gra-1922	155	11	ys	ys	PROPN
gra-1922	155	12	,	,	PUNCT
gra-1922	155	13	park	park	PROPN
gra-1922	155	14	ek	ek	PROPN
gra-1922	155	15	,	,	PUNCT
gra-1922	155	16	park	park	NOUN
gra-1922	155	17	js	js	PROPN
gra-1922	155	18	,	,	PUNCT
gra-1922	155	19	et	et	PROPN
gra-1922	155	20	al	al	PROPN
gra-1922	155	21	.	.	PROPN
gra-1922	155	22	weekly	weekly	ADJ
gra-1922	155	23	cisplatin	cisplatin	NOUN
gra-1922	155	24	therapy	therapy	NOUN
gra-1922	155	25	compared	compare	VERB
gra-1922	155	26	with	with	ADP
gra-1922	155	27	triweekly	triweekly	ADJ
gra-1922	155	28	combination	combination	NOUN
gra-1922	155	29	chemotherapy	chemotherapy	NOUN
gra-1922	155	30	as	as	ADP
gra-1922	155	31	concurrent	concurrent	ADJ
gra-1922	155	32	adjuvant	adjuvant	NOUN
gra-1922	155	33	chemoradiation	chemoradiation	NOUN
gra-1922	155	34	therapy	therapy	NOUN
gra-1922	155	35	after	after	ADP
gra-1922	155	36	radical	radical	ADJ
gra-1922	155	37	hysterectomy	hysterectomy	NOUN
gra-1922	155	38	for	for	ADP
gra-1922	155	39	cervical	cervical	ADJ
gra-1922	155	40	cancer	cancer	NOUN
gra-1922	155	41	.	.	PUNCT
gra-1922	156	1	int	int	NOUN
gra-1922	156	2	j	j	PROPN
gra-1922	156	3	gynecol	gynecol	ADJ
gra-1922	156	4	cancer	cancer	NOUN
gra-1922	156	5	2011;21:128	2011;21:128	PROPN
gra-1922	156	6	-	-	SYM
gra-1922	156	7	36	36	NUM
gra-1922	156	8	.	.	PUNCT
gra-1922	156	9	13	13	NUM
gra-1922	156	10	.	.	PUNCT
gra-1922	157	1	chumworathayi	chumworathayi	PROPN
gra-1922	157	2	b	b	PROPN
gra-1922	157	3	,	,	PUNCT
gra-1922	157	4	suprasert	suprasert	NOUN
gra-1922	157	5	p	p	NOUN
gra-1922	157	6	,	,	PUNCT
gra-1922	157	7	charoenkwan	charoenkwan	PROPN
gra-1922	157	8	k	k	NOUN
gra-1922	157	9	,	,	PUNCT
gra-1922	157	10	srisomboon	srisomboon	PROPN
gra-1922	157	11	j	j	PROPN
gra-1922	157	12	,	,	PUNCT
gra-1922	157	13	phongnarisorn	phongnarisorn	ADJ
gra-1922	157	14	c	c	NOUN
gra-1922	157	15	,	,	PUNCT
gra-1922	157	16	siriaree	siriaree	PROPN
gra-1922	157	17	s	s	PROPN
gra-1922	157	18	,	,	PUNCT
gra-1922	157	19	et	et	PROPN
gra-1922	157	20	al	al	PROPN
gra-1922	157	21	.	.	PROPN
gra-1922	157	22	weekly	weekly	PROPN
gra-1922	157	23	versus	versus	ADP
gra-1922	157	24	three	three	NUM
gra-1922	157	25	-	-	PUNCT
gra-1922	157	26	weekly	weekly	NOUN
gra-1922	157	27	cisplatin	cisplatin	NOUN
gra-1922	157	28	as	as	ADP
gra-1922	157	29	an	an	DET
gra-1922	157	30	adjunct	adjunct	ADJ
gra-1922	157	31	to	to	ADP
gra-1922	157	32	radiation	radiation	NOUN
gra-1922	157	33	therapy	therapy	NOUN
gra-1922	157	34	in	in	ADP
gra-1922	157	35	high	high	ADJ
gra-1922	157	36	-	-	PUNCT
gra-1922	157	37	risk	risk	NOUN
gra-1922	157	38	stage	stage	NOUN
gra-1922	157	39	i	i	PRON
gra-1922	157	40	-	-	PUNCT
gra-1922	157	41	iia	iia	VERB
gra-1922	157	42	cervical	cervical	ADJ
gra-1922	157	43	cancer	cancer	NOUN
gra-1922	157	44	after	after	ADP
gra-1922	157	45	surgery	surgery	NOUN
gra-1922	157	46	:	:	PUNCT
gra-1922	157	47	a	a	DET
gra-1922	157	48	randomized	randomized	ADJ
gra-1922	157	49	comparison	comparison	NOUN
gra-1922	157	50	of	of	ADP
gra-1922	157	51	treatment	treatment	NOUN
gra-1922	157	52	compliance	compliance	NOUN
gra-1922	157	53	.	.	PUNCT
gra-1922	158	1	j	j	PROPN
gra-1922	158	2	med	med	PROPN
gra-1922	158	3	assoc	assoc	PROPN
gra-1922	158	4	thai	thai	PROPN
gra-1922	158	5	2005;88:1483	2005;88:1483	PROPN
gra-1922	158	6	-	-	PUNCT
gra-1922	158	7	92	92	NUM
gra-1922	158	8	.	.	PUNCT
gra-1922	159	1	14	14	NUM
gra-1922	159	2	.	.	PUNCT
gra-1922	160	1	akhila	akhila	NOUN
gra-1922	160	2	vishwanathan	vishwanathan	PROPN
gra-1922	160	3	c.halperin	c.halperin	PROPN
gra-1922	160	4	dew	dew	NOUN
gra-1922	160	5	et	et	PROPN
gra-1922	160	6	al	al	PROPN
gra-1922	160	7	p	p	PROPN
gra-1922	160	8	and	and	CCONJ
gra-1922	160	9	,	,	PUNCT
gra-1922	160	10	by	by	ADP
gra-1922	160	11	bp	bp	PROPN
gra-1922	160	12	and	and	CCONJ
gra-1922	160	13	practice	practice	NOUN
gra-1922	160	14	of	of	ADP
gra-1922	160	15	radiation	radiation	NOUN
gra-1922	160	16	oncology	oncology	NOUN
gra-1922	160	17	.	.	PUNCT
gra-1922	161	1	perez	perez	PROPN
gra-1922	161	2	and	and	CCONJ
gra-1922	161	3	brady	brady	PROPN
gra-1922	161	4	’s	’s	PART
gra-1922	161	5	principles	principle	NOUN
gra-1922	161	6	and	and	CCONJ
gra-1922	161	7	practice	practice	NOUN
gra-1922	161	8	of	of	ADP
gra-1922	161	9	radiation	radiation	NOUN
gra-1922	161	10	oncology	oncology	NOUN
gra-1922	161	11	6th	6th	NOUN
gra-1922	161	12	edition	edition	NOUN
gra-1922	161	13	by	by	ADP
gra-1922	161	14	edward	edward	PROPN
gra-1922	161	15	chapter	chapter	PROPN
gra-1922	161	16	69	69	NUM
gra-1922	161	17	uterine	uterine	ADJ
gra-1922	161	18	cervix	cervix	NOUN
gra-1922	161	19	may	may	AUX
gra-1922	161	20	06	06	NUM
gra-1922	161	21	,	,	PUNCT
gra-1922	161	22	2013	2013	NUM
gra-1922	161	23	.	.	PUNCT
gra-1922	162	1	15	15	NUM
gra-1922	162	2	.	.	PUNCT
gra-1922	162	3	hennequin	hennequin	PROPN
gra-1922	162	4	c	c	PROPN
gra-1922	162	5	,	,	PUNCT
gra-1922	162	6	favaudon	favaudon	PROPN
gra-1922	162	7	v.	v.	ADP
gra-1922	162	8	biological	biological	ADJ
gra-1922	162	9	basis	basis	NOUN
gra-1922	162	10	for	for	ADP
gra-1922	162	11	chemo	chemo	NOUN
gra-1922	162	12	-	-	PUNCT
gra-1922	162	13	radiotherapy	radiotherapy	NOUN
gra-1922	162	14	interactions	interaction	NOUN
gra-1922	162	15	.	.	PUNCT
gra-1922	163	1	eur	eur	PROPN
gra-1922	163	2	j	j	PROPN
gra-1922	163	3	cancer	cancer	PROPN
gra-1922	163	4	2002;38:223	2002;38:223	NUM
gra-1922	163	5	-	-	SYM
gra-1922	163	6	30	30	NUM
gra-1922	163	7	16	16	NUM
gra-1922	163	8	.	.	PUNCT
gra-1922	164	1	anusha	anusha	VERB
gra-1922	164	2	konakalla	konakalla	PROPN
gra-1922	164	3	v	v	PROPN
gra-1922	164	4	l	l	NOUN
gra-1922	164	5	,	,	PUNCT
gra-1922	164	6	das	das	PROPN
gra-1922	164	7	p	p	PROPN
gra-1922	164	8	,	,	PUNCT
gra-1922	164	9	swapna	swapna	PROPN
gra-1922	164	10	j	j	PROPN
gra-1922	164	11	,	,	PUNCT
gra-1922	164	12	jena	jena	PROPN
gra-1922	164	13	a	a	PROPN
gra-1922	164	14	,	,	PUNCT
gra-1922	164	15	radhika	radhika	PROPN
gra-1922	164	16	k	k	PROPN
gra-1922	164	17	,	,	PUNCT
gra-1922	164	18	rao	rao	PROPN
gra-1922	164	19	b	b	PROPN
gra-1922	164	20	s	s	PROPN
gra-1922	164	21	,	,	PUNCT
gra-1922	164	22	kuna	kuna	PROPN
gra-1922	164	23	j	j	PROPN
gra-1922	164	24	,	,	PUNCT
gra-1922	164	25	jagannathrao	jagannathrao	PROPN
gra-1922	164	26	naidu	naidu	PROPN
gra-1922	164	27	k	k	PROPN
gra-1922	164	28	v	v	PROPN
gra-1922	164	29	,	,	PUNCT
gra-1922	164	30	subramanian	subramanian	PROPN
gra-1922	164	31	b	b	PROPN
gra-1922	164	32	v.	v.	ADP
gra-1922	164	33	a	a	DET
gra-1922	164	34	prospective	prospective	ADJ
gra-1922	164	35	randomised	randomised	ADJ
gra-1922	164	36	study	study	NOUN
gra-1922	164	37	on	on	ADP
gra-1922	164	38	comparison	comparison	NOUN
gra-1922	164	39	of	of	ADP
gra-1922	164	40	weekly	weekly	ADJ
gra-1922	164	41	versus	versus	ADP
gra-1922	164	42	3	3	NUM
gra-1922	164	43	weekly	weekly	ADJ
gra-1922	164	44	cisplatin	cisplatin	NOUN
gra-1922	164	45	chemotherapy	chemotherapy	NOUN
gra-1922	164	46	as	as	ADP
gra-1922	164	47	an	an	DET
gra-1922	164	48	adjunct	adjunct	ADJ
gra-1922	164	49	to	to	PART
gra-1922	164	50	radiotherapy	radiotherapy	VERB
gra-1922	164	51	in	in	ADP
gra-1922	164	52	treatment	treatment	NOUN
gra-1922	164	53	of	of	ADP
gra-1922	164	54	carcinoma	carcinoma	NOUN
gra-1922	164	55	of	of	ADP
gra-1922	164	56	the	the	DET
gra-1922	164	57	uterine	uterine	ADJ
gra-1922	164	58	cervix	cervix	NOUN
gra-1922	164	59	.	.	PUNCT
gra-1922	165	1	j	j	PROPN
gra-1922	165	2	clin	clin	PROPN
gra-1922	165	3	sci	sci	PROPN
gra-1922	165	4	res	re	VERB
gra-1922	165	5	2018;7:12	2018;7:12	NOUN
gra-1922	165	6	-	-	SYM
gra-1922	165	7	8	8	NUM
gra-1922	165	8	x	x	SYM
gra-1922	165	9	57gjra	57gjra	PROPN
gra-1922	165	10	global	global	ADJ
gra-1922	165	11	journal	journal	PROPN
gra-1922	165	12	for	for	ADP
gra-1922	165	13	research	research	NOUN
gra-1922	165	14	analysis	analysis	NOUN
gra-1922	165	15	volume-9	volume-9	NUM
gra-1922	165	16	,	,	PUNCT
gra-1922	165	17	issue-2	issue-2	PROPN
gra-1922	165	18	,	,	PUNCT
gra-1922	165	19	february-2020	february-2020	VERB
gra-1922	165	20	•	•	NUM
gra-1922	165	21	print	print	NOUN
gra-1922	165	22	issn	issn	PROPN
gra-1922	165	23	no	no	NOUN
gra-1922	165	24	.	.	PROPN
gra-1922	165	25	2277	2277	NUM
gra-1922	165	26	8160	8160	NUM
gra-1922	165	27	•	•	NOUN
gra-1922	165	28	doi	doi	NOUN
gra-1922	165	29	:	:	PUNCT
gra-1922	165	30	10.36106	10.36106	NUM
gra-1922	165	31	/	/	SYM
gra-1922	165	32	gjra	gjra	NOUN